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[1] Supplementary Methods: Data extraction  
 
Correlation coefficients (adjusted and unadjusted), n (number of participants), beta 
coefficients (standardized and unstandardized) for the relationship between protein intake 
(g/Kg/d or g/d) and bone outcomes were extracted, as well as bone outcomes by protein 
intake category.  Data for calcium intakes were also extracted. For correlational studies 
looking at the association between change in bone outcomes over time and baseline protein 
intake, or assessing associations between protein intake and bone outcomes at different time 
points, all relevant data were extracted.  This included mean and standard deviation (SD) for 
change in bone indices over time, or else r coefficients or beta coefficients for slope of bone 
loss in different protein intake groups. It also included bone outcomes by protein intake 
category.  
For studies presenting data on risk of fracture or osteoporosis/osteopenia diagnosis, odds 
ratios, hazard ratios or relative risk estimates (with 95% confidence intervals) for the highest 
and lowest categories of protein intakes were extracted, with n and p if available.  Mean and 
SD for protein intakes in cases and controls were extracted if no other data were presented 
(e.g. no risk estimates, no categories of intake data).  
Finally, for the intervention studies, as subjects were randomized at baseline, only the mean, 
SD and n for follow up measurements were extracted for each relevant outcome in each study 
arm. Standard errors of the mean (SEM) were converted to standard deviations using the 
IRUPXOD6(0 6'¥Q3DSHUVQRWSURYLGLQJFRPSOete data to calculate standardized size 
effects (i.e. not able to calculate the standard deviation, or the standard error of the mean) 
were excluded from the meta-analysis if this data could not be obtained from the relevant 
authors.  Two authors of relevant articles with missing data were contacted.  Neither of the 
authors replied so their papers were not included in the meta-analysis, but the general 
findings were included in the systematic review.  Two other authors, whose papers had 
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missing data, or data only available in figures, was not contacted as previous contact when 
doing the original analysis in 2007 was not successful.  
[2] Supplementary Results: Studies reporting correlation or regression coefficients for 
the relationship between dietary protein and bone indices 
 
Study Characteristics 
Of the 74 studies presenting data for correlation or regression coefficients, 18 studies were 
from South or East Asia (1-17), 21 from Europe(18-38),  2 from the Middle East (39, 40), 6 
from Australia, Tasmania or New Zealand(41-46), 25 from USA or Canada (47-71) and 2 
from South America(72, 73).  Of these 74 studies, 12 were in children or adolescents (3, 17-
21, 24, 25, 37, 38, 45, 48), with 1 study combining data from adults and children (44).  Also, 
13 studies were in premenopausal women (1, 4, 14, 15, 29, 30, 32, 43, 47, 52, 57, 62, 74), 21  
in postmenopausal women (2, 6-8, 11, 12, 16, 22, 33, 39-42, 46, 55, 59, 61, 63, 65, 70, 72), 7  
in both pre and postmenopausal women(9, 10, 27, 34, 49-51), 2 in both peri and 
postmenopausal women(5, 53), 5 in men(31, 36, 66, 67, 73), 1 in pre, peri or postmenopausal 
women(26) and 13 in both men and women(13, 23, 28, 35, 56, 58, 60, 64, 68, 69, 71, 75).  
Sixty-one studies assessed total protein intake only but 2 studies assessed both soy and total 
protein(5, 8), one study assessed soy protein only(6), 10 studies assessed animal and/or 
vegetable protein intake in addition to total protein(7, 15, 16, 19, 20, 34, 47, 54, 58, 71) and 
one study assessed soy, animal, vegetable and total protein(13). 
 
Systematic Review: Studies reporting correlation or regression coefficients, or protein 
category data 
Seventy-four studies presented correlation coefficient (r) or regression coefficient data 
(standardized (Beta) or unstandardized (B)) data (Table 1).  
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Cross-sectional data- BMD  
In adults a large number of studies found an association between protein intake and Bone 
Mineral Density (BMD) at the hip (23, 27, 32, 36, 39, 41-43, 49, 55, 58, 60, 66, 72), radius 
(4, 49, 57, 58), spine(9, 23, 27, 32, 43, 52, 60, 62, 63, 66, 72), total body (27, 55, 56, 58, 62, 
66, 68) or hand (HBMD) (55). Conversely, a large number of studies found that protein 
intake was not associated with BMD at the hip (1, 2, 9, 11, 22, 28-30, 35, 36, 47, 49, 50, 52, 
58, 60, 63, 65, 72, 73), spine (1, 2, 8, 11, 22, 28-30, 35, 39, 47, 49, 50, 54, 58, 60, 65), radius 
(32, 49, 53, 61) or total body (50, 58, 64).  See Supplemental Material for a review of adult 
studies assessing animal and vegetable protein intake specifically.  In children, two studies 
found that total protein and animal protein intakes were not associated with femoral neck 
(FN) BMD or lumbar spine (LS) BMD(45). However, two other studies conflicted as to 
whether or not protein intake was associated with total body BMD (TBBMD) (45, 48).  
 
Cross-sectional data- BMC and Bone Size 
In children, seven studies showed that higher protein intake was associated with increased 
radial periosteal circumference, cortical area, volumetric BMC (vBMC) and polar SSI(18, 
38), as well as TBBMC(3, 24, 48), total body bone area (TBBA)(3, 24), total radial BMC 
(RBMC)(21), radial metaphyseal BMC(21), femoral neck BMC (FNBMC)(21), femoral 
diaphysis BMC(21) and lumbar spine BMC (LSBMC)(21).  Likewise, another study 
indicated that there was a positive association between dietary protein and forearm cortical 
BA but not forearm vBMC(25).  However, one study found no association between child 
protein intake and radial diaphysis BMC or total hip BMC (THBMC)(21) and another found 
that total protein and animal protein intakes were not associated with total body BMC 
(TBBMC) or lumbar spine BMC (LSBMC)(19).  In adults, a large number of studies found a 
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positive association between total protein intake and RBMC(10, 32, 33, 44, 57, 61), 
TBBMC(55, 62, 72), Spine BMC (62, 67), LSBMC(32) TBBMC(68) and HipBMC(32), but 
three studies found no association between protein intake and RBMC(33, 51, 67), humerus 
BMC(51) or Ulna BMC(51).   
 
Cross-sectional data- quantitative ultrasound (QUS) and bone makers 
There were no studies of BUA in children.  In adults, four studies found that protein intake 
was positively associated with calcaneal BUA(15, 34, 41, 52). In one of these studies total 
protein intake was negatively associated with calcaneal BUA but the association disappeared 
when adjusting for animal: vegetable protein ratio(34).  In terms of bone markers, in children 
the one study assessing bone markers found a positive association between protein intake and 
bone alkaline phosphatase (BAP), but found no association with osteocalcin (OC) or c-
telopetide of collagen (CTx) (20).  In adults, in four studies increased total protein intake was 
negatively associated with hydroxyproline  (HPO) (premenopausal women only) (49), 
CTX(42), pyridinoline (PYD)(8, 26), deoxypyridinoline (DPYD)(26) and type 1 n-terminal 
procollagen (P1NP)(42).  In contrast, one study found a positive association between total 
protein intake and CTX(31) and other studies found no association between total protein 
intake and HPO (postmenopausal women only)(49), OC(8, 12, 27, 49, 50, 59), n-terminal 
telopeptide (NTX)(12, 50, 59), DPYD(8, 12) or BAP(8, 12).  
Systematic Review: Animal, vegetable or soy protein and bone health 
Studies in adults 
In four studies, animal protein intake was not associated with FNBMD (7, 47), LSBMD(7, 
47), TBBMD(7) LSvBMD(54), THBMD(47) or calcaneal stiffness index (13). One study 
found a positive association between spine BMD and non-dairy animal protein intake in 
postmenopausal women aged 50 years or older, but conversely in premenopausal women 
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found a negative association (71). One study found increasing animal protein was associated 
with increased THBMD, FNBMD, TSBMD, TBBMD(58).  One study found a negative 
association between BUA of the calcaneus with animal protein, the effect being modified by 
calcium intake (34). Finally, another study found that increased animal: vegetable protein 
ratio was a negative predictor of FNBMD (16).  
Two studies found that vegetable protein was not associated with FNBMD and LSBMD(7) or 
calcaneal stiffness index(13). However a negative association was found in three studies 
between plant protein and spine BMD (16, 71) or TBBMD (7, 47) and hip BMD (47, 58, 71). 
Interestingly, one study found that higher vegetable protein intake was associated with 
reduced LSvBMD in persons of White (but not Chinese, Black or Hispanic) ethnicity (54).  
Increasing vegetable protein was associated in another study with reduced THBMD, FNBMD 
and TSBMD in women but not men (58).  Conversely, one study found a positive association 
between vegetable protein intake and bone heath for calcaneal BUA (34). 
In terms of soy protein, four studies showed no association with calcaneal stiffness index 
(13), LSBMD(5, 6) , FNBMD (5, 6), TBBMC(5, 6, 44), THBMC(5), THBMD(6), or 
TBBMD(6), Troch/intertroch BMD (6) or leg BMC(44). However, two studies found that 
increased soy protein intake was associated with lower DPYD(8) or higher LSBMD (8),  but 
no association with PYD, ALP  or OC(8).  
 
Studies in children 
In children, one study found no association between animal (meat) protein intake and 
TBBMC or LSBMC, but did find a positive association between BAP and animal protein 
intake (19). However, there was no association between animal or vegetable protein intake 
and OC or CTX, or between vegetable protein and BAP(20). Conversely, another paper from 
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the same group found a positive association between animal protein intake and OC, CTX and 
BAP(19). There were no studies of soy protein intake in children or adolescents. 
 
Systematic Review: Studies reporting r values for slope of change in bone mass  
In children, one study in boys found that baseline protein intake (age 7 years) was not 
associated with FN vBMD, Total hip vBMD, distal tibia vBMD, FNBA, FN width, total hip 
aBMD or FN aBMD at age 15 years when physical activity levels were lower (37), but 
protein intake was positively associated when physical activity levels were higher (37).   
Another study, in pre-pubertal girls with low calcium intakes, found increased animal protein 
intake was associated with lower gain in Radial BMC and TBBMC from age 10 to 15 years 
(17).  
In adults, one study found no relationship between baseline intake of total, animal or 
vegetable protein and 3 year change in hip, spine or TBBMD(47) with another finding no 
association between protein intake and bone loss, also over 3 years (59). Another study found 
no association between protein intake and loss of LSBMD, FNBMD, THBMC or TBBMC 
over 30 months (5). 
Similarly, one study found no association between protein intake during adolescence (15 
years old) and subsequent LSBMD or FNBMD in young adulthood (20-25y old)(28). Finally, 
another found no association between BUA, BV or SOS in 18-19 year old women and 
previous protein intake at 9-11 years old (74).  No relationship between protein intake and 
total hip BMD(75). Sahni 2014 found a negative association in men between protein intake 
and % change in TrochBMD but not % change in LS or FN BMD in men, but there were no 
associations at any site for women (60).  
However, some studies have found an association between protein intake and change in bone 
mass.  One study found increased protein intake at age 20-25 years was retrospectively 
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associated with increased gain in TBBMC from peri-adolescence to the present day, in 
females with adequate calcium intake as well as all males regardless of calcium intake (64). 
One study found that for every 20% increase in % of total energy from dietary protein, over a 
6 year period, there was an increase of 0.003 to 0.004g/cm2 for TBBMD, HipBMD and Spine 
BMD(70).  Another study found reduced FNBMD and LS BMD loss (but no change in radial 
shaft BMD) over a 4 year period in those in with the highest (vs. lowest) quartile of protein 
intake(69). Finally, another study found an association between higher protein intake and 
reduced radial bone loss (BMD) in both pre and postmenopausal women(51). Another study 
in elderly women found a positive association between baseline protein intake and BMC 5 
years later with the highest daily protein intake tertile (>87g/d) being associated with higher 
appendicular and whole body BMC than the lowest quartile (<66g/d)(46). Finally, in one 
VWXG\RIPHQDQGZRPHQDJHG\HDUVROGWKHUHZDVDSRVLWLYHDVVRFLDWLRQEHWZHHQ
baseline total protein intake and BMD 5 years later at the hip, as well as a positive association 
between protein intake and Spine BMD for both men and women, and with Hip BMD for the 
women only (71).   
Conversely, one study found increased bone loss in men with higher protein intake (60). A 
negative association between vegetable protein intake and % change in LSBMD, as well as 
between AP:VP ratio and FNBMD(16).  Another study found increased bone loss in women 
consuming high animal: vegetable protein ratio diets than those consuming low animal: 
vegetable protein ratio diets (76). One study found that higher quartiles of soy protein intake 
were associated with protection against loss of TBBMC(5).  Another study found no 
association between soy intake and loss of LSBMD, FNBMD, THBMC or TBBMC over 30 
months (5). 
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Meta-analysis: Funnel Plots and Sensitivity analyses for FNBMD and LSBMD models 
Funnel plots were conducted for the following models: FNBMD (unadjusted and adjusted); 
LSBMD (unadjusted and adjusted), BMD in postmenopausal women and BMD in 
premenopausal women. The FNBMD plot showed all studies within the 95% confidence 
interval boundaries but there were a lack of smaller studies showing a negative effect 
estimate. The LSBMD plot had 3 out of 18 studies outside the 95% confidence interval 
boundary (strong positive effect sizes) showing, as with FNBMD, a lack of smaller studies in 
the negative effect estimate area.  The funnel plot for postmenopausal women BMD showed 
few small studies with a negative effect, and the premenopausal women BMD plot showed 3 
studies out of 10 outside the 95% confidence interval area (strong positive effect sizes) and a 
lack of medium sized studies in the negative effect estimate area. Taken together, this 
suggests potential publication bias in terms of smaller to medium studies, particularly those 
with negative associations between protein and bone health, not being published. 
In terms of sensitivity analyses, removal of each study in turn for the FNBMD analysis 
(confounder adjusted data only) had little effect on the above results.  Sensitivity analyses 
show effect sizes as follows when each study excluded in turn: Chan 2009 r(random)=0.07 (-
0.04 to 0.18) R2=0.005 (0.5%) P=0.21, I2=47% P(heterogeneity)=0.15;  Cooper 1995 
Postmenopausal data r(random)=0.05 (-0.06 to 0.17) R2=0.003 (0.3%), P=0.37, I2=63% 
P(heterogeneity)=0.07; Cooper 1995 Premenopausal data r(fixed)=0.01(-0.05 to 0.07) R2=<0.001 
(<0.1%) P=0.33, I2=0% P(heterogeneity)=0.67; Ho2003 r(random)=0.05 (-0.08 to 0.19) R2=0.003 
(0.3%) P=0.43, I2=62% P(heterogeneity)=0.07. However, removal of the Cooper et al. (1995)(49) 
premenopausal data reduced heterogeneity to 0%, suggesting this study contributed strongly 
to the heterogeneity.  Exclusion of this study also reduced the effect size from 0.07 to 0.01, 
suggesting it was increasing the effect size substantially.  However, the R2 was still very 
small (<0.1% to 0.5%) and not statistically significant when any of the studies were removed, 
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or all included (0.2%). Therefore removal of studies had little overall effect on the pooled 
effect size. 
In terms of sensitivity analyses for LSBMD (confounder adjusted data only), the following 
pooled effect sizes were found when each study in turn were excluded: Ho 2003(6) r(fixed)=-
0.021 (-0.14 to 0.10) R2=<0.001 (0.1%) P=0.73, I2=0% P(heterogeneity)=0.39;  Cooper 1995(49) 
Postmenopausal r(fixed)= 0.02 (-0.06 to 0.11) R2<0.001 (0.1%) P=0.60, I2=0% 
P(heterogeneity)=0.68; Cooper 1995(49) Premenopausal r(fixed) = -0.01 (-0.08 to 0.07) R2=<0.001 
(0.1%) P=0.88, I2=0% P(heterogeneity)=0.43.  The pooled effect size was unchanged by the 
elimination of any studies in the model, suggesting no studies were having a strong impact on 
the overall effect size. 
 
Meta-analysis: Associations with protein and calcium dose, as well as calcium: protein 
ratio 
Linear, quadratic and cubic regression models (not controlling for confounders) showed that 
neither the calcium: protein ratio (calcium mg/protein g), nor the protein (g/kg/d) or calcium 
(mg/kg/d) dose, were associated with correlation (r) coefficients for the association between 
protein intake and bone health for either LSBMD or FNBMD (P values were P >0.05 or did 
not survive multiple testing adjustment (revised cutoff of P>0.001)). There was a positive 
association between protein intake and both FNBMD and LSBMD in the linear model (both 
P=0.02, b=0.33-0.39) and a negative association in the cubic models (P=0.01 (b= -0.90) for 
FNBMD and P=0.009 (b= -0.84) for LSBMC) but these models did not survive adjustment 
for multiple testing (P>0.001). See Supplemental Table 6 for full details of these analyses. 
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[3] Supplementary Results: Studies reporting fracture or osteoporosis risk 
 
Study Characteristics 
 
Of the 29 studies (including six studies already reported in correlation coefficient or bone 
slope sections), 4 were from Asia (2, 14, 77, 78), 11 were from the USA or Canada (70, 71, 
76, 79-86) , 2 were from the Middle East (40, 87) 1 was from New Zealand(42) and 9 were 
from Europe (36, 88-95).  In addition, 2 studies were by authors from the USA but reported 
data from multiple countries (96, 97).   
In terms of study design, 13 studies were cohort studies (70, 71, 76, 78-84, 88, 92, 94), 2 
were ecological studies (96, 97), 3 were of cross-sectional design (2, 36, 42)  and 11 were 
case-control studies (14, 40, 77, 85-87, 89-91, 93, 95).  Of the latter, only 2 were prospective 
(nested) case-control studies (89, 93).  In terms of fracture type, of the 13 cohort studies, 7 
assessed hip fracture only(70, 76, 80-83, 94), 1 assessed hip, spine and forearm/wrist fracture 
(84), one study assessed hip and forearm/wrist fractures (79), two studies assessed all 
fragility fractures combined (71, 88)  and two studies assessed all fractures (fragility and non-
fragility)(78, 92).  The 2 ecological studies assessed just hip fracture incidence (96, 97). 
For the 11 case-control studies, 1 study was in children, assessing dietary protein intake in 
children with fracture compared with children without fracture (93).  The other 10 studies 
were all in adults, 1 assessing odds of hip fracture(86), 1 assessing odds of all fragility 
fractures by protein intake(91), 4 assessing differences in protein intake in hip, spine or wrist 
fracture cases and controls (89) or between osteoporotic/osteopenic cases vs. controls (14, 40, 
87), 2 assessing odds of hip fracture only by protein intake(85, 95) and 2 assessing odds of 
osteoporosis diagnosis by protein intake category(77, 90).  
In terms of population studied, 6 of the 13 cohort studies were in postmenopausal women(70, 
76, 78, 81, 84, 88), 1 in pre and postmenopausal women(79),  5 in men and women(71, 80, 
83, 92, 94) and 1 in men only(82).  In the 11 case-control studies, 1 was in children(93), 3 
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studied men and women(86, 89, 91), 1 studied premenopausal women(14) and 6 studied 
postmenopausal women(40, 77, 85, 87, 90, 95). 
Six cohort studies and the 3 cross-sectional studies assessed total dietary protein only (2, 36, 
42, 70, 71, 80, 82, 84, 92), 1 studied animal protein only(94), 1 studied soy protein only(78) 
and 5 studied total dietary protein, animal protein and vegetable protein(76, 79, 81, 83, 88). 
The 2 cross cultural studies assessed the relationship between protein intake and fracture risk 
in 16 (96) to 33(97) countries worldwide, with Abelow et al.(1992)(96) studying animal 
protein only and Frassetto et al. (2000)(97) studying animal, vegetable and total protein 
intake. In the case-control studies, 7 studies assessed total protein only(14, 40, 85, 87, 89, 93, 
95), whilst 4 assessed total, animal and vegetable protein(77, 86, 90, 91). 
 
Exclusion of studies from fracture risk meta-analysis 
Studies were excluded from the quantitative meta-analysis of fracture risk if they were cross-
cultural studies(96, 97), had only data on risk of osteoporosis or osteopenia (2, 36, 40, 42, 77, 
87, 90), had effect statistics that were incompatible with other studies(70, 92) were the only 
fracture study in children (93) or reporting soy protein(78), only had results that were 
stratified by calcium (84), had missing data (76) or were case-control studies not reporting 
odds ratios (14, 89, 95).  Case-control studies were analysed separately from cohort studies 
due to methodological differences. Cohort studies presenting data on RR and HR were 
analysed separately.  
 
Systematic Review: Studies reporting fracture or osteoporosis risk 
Twenty-nine studies reported data on fracture and/or osteoporosis diagnosis (Table 2), of 
which 28 studies were in adults and one in children (93).  All studies provided multivariate 
adjusted estimates adjusted for multiple confounders (see Table 2) except for one cohort 
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study (76) which controlled for only 2 confounders, 2 ecological studies (96, 97) which were 
only adjusted for age, 2 cross-sectional studies which were only adjusted for BMI or energy 
intake(36, 42), 5 of the case-control studies(14, 40, 87, 89, 93) which presented only 
unadjusted data, and another case-control study which presented categories of intake (non-
statistically analysed) so confounder adjustment was not required (90). 
 
 
Cohort studies- total protein intake 
 
Three studies found no association between total protein and risk of hip (80, 82) or spine 
fractures. In terms of fracture type, three studies found no association between total protein 
intake and either risk of combined fragility and non-fragility fractures (92), just all fragility 
fractures (71, 88) or hip fracture specifically (79, 81, 94).  One study found an increased risk 
with higher total protein intake (79) and another found the reduced risk with higher protein 
intake(70). Finally, another study found increased odds of fracture when calcium intake was 
high and protein intake was low, but this association was attenuated when both calcium and 
protein were high (84). One study found the relationship between protein intake and fracture 
risk depended on calcium intake(83).  
 
Case-control, cross-sectional and ecological studies- total protein intake 
 
The one case-control study in children was of prospective (nested within-cohort) design and 
found no difference in protein intake between fracture cases and controls (93).  All case-
control studies in adults were of retrospective design, with the exception of 1 study that was 
prospective (89). Four adult case-control studies found no significant difference between 
protein intakes in cases with osteoporosis vs. non-osteoporotic controls(90) or 
18 
 
 
 
osteoporotic/osteopenic cases vs. healthy controls (14, 40, 87).  In contrast, one study found 
increased odds of osteoporosis diagnosis with higher total protein intake (77).   Three studies 
found no reduction in odds of being a fracture case in persons with higher protein intake 
compared with low protein intake (85, 91, 95).  However, one study found lower total protein 
intake (non-adjusted for confounders) in cases with fragility fractures than in controls(89), 
and  two studies found an increased odds of fracture(36) or reduced odds of fracture (50-69 
year old subgroup) in persons with higher protein intake (86).  The two cross-cultural 
(ecological) studies found a positive association between hip fracture and total protein intakes 
(97) and a positive association between hip fracture and animal protein intake (96), both 
studies controlling for age only. Two of the 3 cross-sectional studies found  that protein 
intake was a predictor of odds for LS osteopenia(2) or hip BMD below 0.83g/cm2 (men)(36), 
however the 3rd study found that protein intake was not associated with diagnosis of 
osteoporosis or osteopenia(42). 
 
Systematic Review: Animal, Vegetable and Soy Protein and Fracture risk 
In studies that presented data on animal and vegetable protein, one study found no association 
between animal or vegetable protein and fragility fracture(88). Similarly, 2 studies found no 
association between animal or vegetable protein and hip fractures (79, 94), or found an 
association between animal protein intake and hip fracture in persons with lower calcium 
intakes only (83). Other studies found no association between hip fracture risk and animal or 
vegetable protein intake (86), or no difference in odds of being a fragility fracture case in 
persons with varying animal or vegetable protein intake (91).  
However, two other studies did find a significant association between animal protein intake 
and risk of forearm(79) and hip fractures(81), but one study found no association between 
vegetable protein intake and fracture risk(81).  In addition, 1 study found an association 
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between increased animal protein intake and increased hip fracture risk, as well as increased 
risk of hip fracture with increased animal: vegetable protein ratio, and a reduced risk of hip 
fracture with increased vegetable protein intake (76). One study found increased odds of 
osteoporosis with higher animal protein intake, but lower odds with increased vegetable 
protein intake(77). Finally, the 2 cross cultural studies(96, 97) found a positive association 
between animal protein intake and hip fracture incidence as well as a negative association 
between hip fracture incidence and increasing vegetable protein intake(97).  The one cohort 
study assessing the relationship between soy protein intake and fracture risk (all fractures) 
found a reduced risk of fracture in the highest intake quintile of soy protein compared with 
the lowest(78). 
 
Quality Analysis 
Twelve cohort studies were assessed for quality using the Newcastle-Ottawa Cohort study 
assessment tool(98) (scored out of 9). Three studies scored 4-5 (44-55%)(79, 88, 94), 8 
studies scored 6-7 (66-78%)(70, 71, 76, 78, 80, 81, 83, 92) and 1 study scored 8 (89%)(82).  
In addition, 6 case-control studies were assessed using the Newcastle-Ottawa case-control 
study assessment tool (scored out of 10), with 3 studies scoring 3-5(77, 91, 95) and 2 studies 
scoring 6-7 (85, 86).  The nested case-control study by Samieri et al. (2013) (89) (score=8 out 
of 9) was assessed using the cohort study tool as it was deemed more appropriate for the 
study design. As discussed previously, the cross-sectional studies were not analysed for 
quality due to the very large numbers of studies. It was not possible to formally assess the 
quality of the 2 ecological studies (96, 97) as there is no specific tool for this. 
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Fracture risk meta-analysis: Sensitivity and subgroup analysis 
Subgroup analysis showed that when removing Dargent-Molina et al 2008, (which was the 
only study to include non-hip fracture results), pooled estimates were as follows:  animal 
protein intake, (RR (random)=0.83 (0.54 to 1.30, p=0.42, n=3 studies, I2=48% 
P(heterogenity)=0.14)), vegetable protein intake (RR(fixed)=1.20 (0.82 to 1.73, p=0.35, n=2 studies, 
I2=4% P(heterogenity)=0.34)), and total protein intake (RR (random)=0.75 (0.47 to 1.21, p=0.24, 
n=3 studies, I2=22% P(heterogenity)=0.28)).   
In terms of sensitivity analysis, the effect sizes when each study were removed in turn were: 
(see estimates above for removal of Dargent-Molina): Animal Protein: Feskanich: RR 
(random)=0.91 (0.61  to 1.37, p=0.67, n=3 studies, I2=63% P(heterogenity)=0.07); Meyer: RR 
(random)=0.93 (0.63  to 1.37, p=0.71, n=3 studies, I2=63% P(heterogenity)=0.07);  Munger: RR 
(fixed)=1.09 (0.97 to 1.21, p=0.73, n=3 studies, I2=0% P(heterogenity)=0.73). For Vegetable 
Protein: Feskanich: RR (random)=1.13 (0.63  to 2.05, p=0.68, n=2 studies, I2=48% 
P(heterogenity)=0.68); Munger: RR (fixed)=0.96 (0.86  to 1.08, p=0.51, n=2 studies, I2=0% 
P(heterogenity)=0.48). For Total Protein: Feskanich: RR (random)=0.76 (0.42  to 1.39, p=0.38, n=3 
studies, I2=54% P(heterogenity)=0.12); Munger: RR (fixed)=1.05 (0.93  to 1.17, p=0.43, n=3 
studies, I2=0% P(heterogenity)=0.43); Mussolino: RR (random)=0.99 (0.77  to 1.27, p=0.90, n=3 
studies, I2=33% P(heterogenity)=0.22).  Therefore, for all protein types the removal of Munger 
rendered the heterogeneity down to zero, suggesting this study was the cause of the 
heterogeneity observed. Overall statistical significance of the models, for all types of protein, 
were not affected by the removal of any study. 
For the cohort studies reporting hazard ratios, removal of each study in turn led to pooled 
estimates as follows: Langsetmo (Men): HR (random)=0.87 (0.57 to 1.34, p=0.54, n=4 studies, 
I2=47% P(heterogenity)=0.13); Langsetmo (Women): HR (random)=0.82 (0.47 to 1.44, p=0.50, n=4 
studies, I2=50% P(heterogenity)=0.11); Misra: HR (random)=0.89 (0.58 to 1.37, p=0.60, n=4 studies, 
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I2=41% P(heterogenity)=0.16); Sahni(High Calcium): HR (random)=0.84 (0.58 to 1.22, p=0.36, n=4 
studies, I2=49% P(heterogenity)=0.12), Sahni(Low Calcium): HR (fixed)=0.79 (0.64 to 0.97, 
p=0.02, n=4 studies, I2=0% P(heterogenity)=0.66). The removal of Sahni (Low Calcium) data led 
to a statistically significant reduction in fracture risk when protein intake was higher. 
Heterogeneity was also reduced to 0%, suggesting this result was leading to a masking of an 
association between protein and fracture risk shown in the low calcium arm of the Sahni 
study and the other studies in the meta-analysis. 
For case control studies reporting odds ratios the following effect sizes were obtained when 
studies were removed as follows: Martinez-Ramirez: OR (random)=0.65 (0.26 to 1.65, p=0.36, 
n=3 studies, I2=73% P(heterogenity)=0.03); Nieves: OR (random)=0.57 (0.23 to 1.44, p=0.23, n=3 
studies, I2=47% P(heterogenity)=0.15); Wengreen (50-69years old: OR (fixed)=1.10 (0.53 to 2.26, 
p=0.81, n=3 studies, I2=0% P(heterogenity)=0.98); Wengreen (70-89years old: OR (random)=0.61 
(0.25 to 1.51, p=0.29, n=3 studies, I2=70% P(heterogenity)=0.04). All results were still not 
statistically significant when studies were removed in turn. Of note, the removal of Wengreen 
(50 to 59 years old group) did make heterogeneity go down to zero suggesting this study was 
the cause of the heterogeneity observed. There were not enough studies to perform funnel 
plots for each of the fracture meta-analyses. 
 
[4] Supplementary Results: Intervention Studies 
Study Characteristics 
The 30 intervention studies included  2 studies in peri-menopausal women(99, 100), 6 in 
premenopausal women(101-106), 12 in postmenopausal women(107-118),  6 in both men 
and women, of which 4 were elderly groups (119-122) and 2 younger or middle-aged(123, 
124), as well as 2 studies in men alone(125, 126) and 2 in children(127, 128).   Seventeen of 
the 30 studies were from USA or Canada (99, 101, 102, 107-109, 112-117, 119, 120, 123-
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125), with 2 from Switzerland(121, 122), 2 from Australia(111, 118), 1 from Brazil(110), 1 
from Spain(128), 1 from New Guinea(127), 5 from Japan(100, 103, 104, 106, 126)  and 1 
from China(105).  Eight of the 30 studies presented data on soy protein intervention vs. non-
soy protein control (99, 107, 111, 112, 114, 116, 117, 125), 6 presented data on milk basic 
protein (MBP) vs. control (100, 103-106, 126), and 7 studies presented data on other protein 
types (110, 118, 120-122, 127, 128).  Finally, 9 studies assessed dietary interventions, 
comparing higher vs. lower protein intakes (101, 102, 108, 109, 113, 115, 119, 123, 124). 
 
Jadad Scores 
See Supplementary Table x for full details of study quality and risk of bias in the 30 
intervention studies.  In terms of Jadad scores (0-5, 5=highest quality), 16 studies were scored 
as 0-2(101, 102, 104-106, 108, 111, 113, 115, 116, 119, 121, 123, 126-128), 7 studies as 3-
4(99, 100, 107, 114, 120, 124, 125) and 7 studies as 5(103, 109, 110, 112, 117, 118, 122).  
Some studies (101, 102, 108, 109, 113, 115, 119, 124) may have scored lower than expected 
due to being dietary intervention studies, whereby it is difficult to undertake participant 
blinding as the different diets are difficult to conceal. Indeed, the Jadad scale is really 
intended for quality assessment of studies were participants and investigators can feasibly be 
blinded to treatment allocation.  Study quality was variable, with many studies having 
significant methodological flaws.   
 
Intervention Studies 
 
Non-dietary Studies- Bone markers 
In soy protein (vs. non-soy protein control) studies, six studies found no effect of soy protein 
on BAP(99, 107, 114, 125), NTX(114, 117), DPYD or PYD(107, 111, 125).  However there 
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was an effect of soy protein vs. milk protein on reducing both BAP and CTx in one 
study(112) and in another study there was a positive effect of soy protein on raising BAP and 
OC, but no effect on NTX(116). Of the three MBP studies reporting bone marker data, one 
study found no effect of MBP supplementation vs. inactive placebo on NTX and OC 
concentration(100),  another study found a lower NTX and higher OC in the MBP group than 
the inactive placebo control(126) and the final study found lower NTX and DPYD in the 
MBP group than inactive placebo(106).  
For total protein (vs non-protein control), protein supplementation was associated with 
increases in type 1 N-terminal procollagen (P1NP)(120), HPO(124), DPYD(122, 124) and 
PYD(122, 124).   There were conflicting results for CTX and OC with three studies finding 
no effect (110, 120, 122) one study finding a reduction in CTX (120) and one finding an 
increase in OC (121). Finally, one study found no statistically significant for an effect of 
protein supplementation on BAP (110). The only study in children found no statistically 
significant difference in BAP or OC or tartrate-resistant acid phosphatase (TRAP), but there 
was a higher increase in CTX over the study period in controls (increase by 6% of baseline 
value) than in the collagen supplemented group (increase by 3% of baseline value). 
 
Dietary Studies- Bone markers 
Seven diet studies found no differential effect of high and low protein diets on CTX (109, 
115), OC(101, 102, 109, 115, 119), DPYD(108) or NTX(108). Four studies found a lower 
NTX (101, 102, 119, 123) and two studies found that DPYD was lower(113) or HPO was 
higher(115) in those taking a high protein diet (compared with a low protein diet).  Finally, 
two studies conflicted in that they found either a higher BAP(102) or no difference in 
BAP(123) in those with a low protein compared with those with moderate or high protein 
diets.  
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Soy and MBP protein and BMD/BMC 
In all supplementation studies no differential effect of soy protein vs. non-soy protein was 
seen for LSBMD(99, 112, 114, 117), LSBMC(99), FNBMD(112, 114, 117), RBMD(114) or 
TBBMD(112, 114, 117).  Also, in a food based study (107) there was no differential effect of 
soy or non-soy protein on both BMD and BMC at the LS, TB and TH. (107). For MBP, a 
statistically significant effect of MBP supplementation in increasing LSBMD was found in 
two studies by 1 - 1.6%(100, 103) and in one study increasing TBBMD by 2%(105). 
However other results for MBP were conflicting, with studies finding either increased 
RBMD(104) or no effect on RBMD LSBMD or TBBMD (105).  
 
 
Total protein and BMD/Bone size 
For total protein, in malnourished New Guinea children aged 7-13 years, one study found an 
effect of 20g/d milk protein supplementation ( vs. no supplement) for increased periosteal 
breadth, but not endosteal or compact bone breadth (127). In adults, no effect was seen for 
protein supplementation vs. non-protein control on LSBMD(120-122),  THBMD(118, 120), 
FNBMD(118, 120, 121) FSBMD(121, 122) or TBBMD(122). Finally, one study found no 
differential effect of high vs low protein supplement drink on TH vBMD or FN vBMD(118). 
 
Meta-analysis: MBP and Soy Protein Sensitivity analysis 
Elimination of each MBP study in turn gave the following pooled estimates: Aoe 2005 
MD(fixed)= 0.01 (-0.04 to 0.07) R2<0.001 P=0.69, I2=0% P(heterogenity)=0.69; Uenishi 2007 
MD(fixed)=0.02 (-0.003 to 0.04) R2=0.0004 P=0.10, I2=0% P(heterogenity)=0.63; Zou 2009 
MD(fixed)= 0.02 (-0.002 to 0.04) R2=0.04 P=0.07, I2=0% P(heterogenity)=0.07.  Elimination of 
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each soy protein study in turn gave the following pooled effect sizes: Alekel 2000 
MD(random)=0.02 (-0.07 to -0.12, P=0.61) I2=52% P(heterogenity)=0.15; Kenny2009 MD(fixed)= -
0.03 (-0.07 to 0.02, P=0.23) I2=8% P(heterogenity)=0.30; Vupadhyahula 2009 MD(random)=0.01 (-
0.14 to 0.15, P=0.93) I2=75% P(heterogenity)=0.04.  Removal of Kenny 2009 reduced 
heterogeneity from 51% to 8%, suggesting this study was contributing to the heterogeneity to 
a large degree.  There were not enough studies to produce funnel plots for these meta-
analyses. 
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Table S1: Characteristics and outcomes of 74 cross-sectional and/or longitudinal correlational studies  
 
Study Mean Protein ** Method  Population n Outcome Coefficient* P 
Alexy et al, 2005,  
Germany 
Prepubescent (M 
and F)- 2.0+/-0.3 
g/Kg/d 
Pubescent (M)- 
1.6+/-0.3 gKg/d 
Pubescent(F)- 1.4+/-
0.3 g/Kgd 
pQCT Prepubescent 
and pubescent 
boys and girls 
229  
 
Periosteal Circumference 
Cortical Area 
BMC 
Polar SSI 
Standardized Beta: protein g/d, adjusted 
for age, sex, energy intake 
0.170.27 
0.26 
0.29 
 
 
 
0.0014 
0.0001 
0.0011 
<0.0001 
Alissa et al, 2011, 
Saudi Arabia 
1.03 g/Kg/d DXA Women aged 
46-70 years 
old 
122 Protein intake Mean (SEM): g/d 
Control: 77.5 (3.15) n 61 
Osteopenic: 76.6 (2.92) n 61 
 
NS 
Alissa et al, 2014, 
Saudi Arabia 
71.4+/-1.55 g/d DXA Postmenopaus
al women, 
aged 46-88 
years 
300  
 
LSBMD 
FNBMD* used pooling  
TotalHipBMD 
Energy adjusted protein intake:  
r values: 
-0.021 
 0.182 
 0.244 
 
 
0.722 
0.002 
 
<0.0001 
Beasley et al. 
2010, USA 
TP: 5.7 - 27.6% 
energy 
AP:45g/d 
VP:19g/d  
 
DXA Females aged 
14-40 years 
560  
 
 
TP: 
TotalHipBMD 
LSBMD 
TBBMD 
 
AP 
TotalHipBMD 
LSBMD 
TBBMD 
 
VP 
TotalHipBMD 
LSBMD 
TBBMD 
 
 
Tertile of protein intake %total energy    
BMD:(Mean, 95% CI) 
 
T1 (lowest)               T3 (highest) 
0.93(0.91,0.95) 0.93 (0.91,0.96)  
1.00 (0.98,1.02)    1.02(1.00,1.04) 
1.08(1.07, 1.09) 1.08(1.06,1.10) 
 
 
0.93(0.91,0.95) 0.94(0.92,0.96) 
1.00(0.98,1.02) 1.02(1.00,1.04) 
1.08(1.07,1.09) 1.08(1.07,1.10) 
 
 
0.92(0.90,0.94) 0.94(0.92,0.96) 
1.00(0.98,1.01) 1.01(0.99,1.04) 
1.07(1.06,1.11) 1.08(1.06,1.09) 
Beta for increment of protein as an extra 
1% energy, adjusted for age, BMI, 
 
 
 
0.94 
0.37 
0.98 
 
 
 
0.99 
0.40 
0.80 
 
 
0.03 
0.10 
0.04 
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N 224:  
3 year change in: 
 
HipBMD 
SpineBMD 
TBBMD 
 
  
HipBMD 
SpineBMD 
TBBMD 
 
 
HipBMD 
SpineBMD 
TBBMD 
physical activity, smoking, contraception, 
energy intake, phosphorus, magnesium. 
 
TP % energy (Year 3)Beta= -0.0002 
Beta=  0.0004 
Beta= -0.0012 
 
AP % energy (Year 3) 
Beta= -0.0002 
Beta= 0.0005 
Beta= -0.0011 
 
VP % energy (Year 3) 
Beta= -0.0023 
Beta= -0.0019 
Beta=  0.0009 
 
 
 
 
 
 
 
P value 
 
0.88 
0.71 
0.19 
 
 
0.87 
0.69 
0.21 
 
 
0.40 
0.50 
0.69 
Beasley et al. 
2014, USA 
15% total energy DXA Postmenopaus
al women 50-
79 years 
144,580  
 
 
TBBMD 
 
 
Hip BMD 
 
 
Spine BMD 
Change in mean BMD per 20% increase in 
%of calories from protein: 
 
At 6 y (n=6552), change in BMD of  0.004 
(0.001, 0.007) g/cm2 
 
At 6 y (n=6553) change in BMD of 0.003 
(0.000, 0.005) 
 
At 6y (n=6457), change in BMD of 
0.003(0.000,0.008) 
 
 
 
- 
 
 
- 
 
 
- 
 
 
Bounds  et al, 
2005, USA 
 
55g/d (1.9g/Kg/d) DXA 6-8 year old 
children 
25 Boys, 
27 
Females 
 
TBBMC 
TBBMD 
TBBMC 
TBBMD 
Unadjusted r values- Pearson¶s 
0.37 
0.33 
Stand.Beta=2.40* 
Stand. Beta=0.001** 
*adjusted for Height,Weight, age and sex 
**adjusted for Sex 
 
 
 
0.008 
0.04 
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Budek et al. 
2007a, Denmark  
2.67 Bone 
turnover 
markers 
N=81 pubertal 
boys 
81 TP 
sOC microg/L  
sBAP U/L 
sCTX microg/L 
 
VP 
sOC microg/L  
sBAP U/L 
sCTX microg/L 
 
Dairy protein 
sOC microg/L  
sBAP U/L 
sCTX microg/L 
 
Meat protein 
sOC microg/L  
sBAP U/L 
sCTX microg/L 
Standardized beta: Age and BMI adjusted 
0.09 
0.89 
<-0.01 
 
 
0.24 
-0.16 
<-0.01 
 
 
-0.45 
0.53 
-0.01 
 
 
0.44 
0.86 
-0.01 
 
0.68 
0.01 
0.59 
 
 
 
0.36 
0.72 
0.29 
 
0.05 
0.16 
0.51 
 
 
0.11 
0.04 
0.35 
Budek et al. 
2007b, Denmark  
TP: 1.2 (Girls), 1.3 
(Boys) 
AP: 0.4 (Girls), 0.5 
(Boys) 
DP: 0.4 (Both Girls 
and Boys) 
DXA 17-year-olds: 
63 girls  and 
46 boys 
109 TP: 
TBBMC 
LSBMC 
 
AP: 
TBBMC 
LSBMC 
Standardized Beta(adj*): 
-0.02 
-0.08 
 
 
 0.01 
-0.01 
*adjusted for bone area, weight, height, 
sex, calcium, energy intake, physical 
activity 
 
0.78 
0.46 
 
 
0.62 
0.78 
Chan et al, 2009, 
Hong 
Kong/Beijing 
77.5g/d Hong Kong 
65.4g/d Beijing 
DXA Premenopausa
l women 
441  
 
TotalHipBMD 
FNBMD 
TotalSpineBMD 
R Protein (g/d): (adjusted for age and 
BMI) 
 
-0.103 
-0.022 
-0.094 
 
 
 
0.359 
ns 
ns 
 
Chan et al. 2011, 
Hong Kong 
1.3 g/Kg/d DXA Older men and 
women 
2217 Energy adjusted protein 
intake 
 
 
B coefficient (adjusted for age, weight, 
height, education, alcohol, smoking, 
physical activity, calcium supplement, 
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% change Hip BMD 
% change FNBMD 
energy adjusted calcium and vitamin D 
intakes) 
Men: 
B= -0.007 
B= -0.013 
Women: data not reported (all ns) 
 
 
0.147  
0.006  
Chevalley et al. 
2008, Switzerland 
47.3 g/d, 1.78 
g/Kg/d 
DXA Prepubertal 
boys 
232  
 
Radial Metaphysis BMC 
Radial Diaphysis BMC 
Total Radius BMC 
FNBMC 
Total Hip BMC 
Femoral Diaphysis BMC 
LSBMC 
 
 
 
Radial Metaphysis BMC 
Radial Diaphysis BMC 
Total Radius BMC 
FNBMC 
Total Hip BMC 
Femoral Diaphysis 
LSBMC 
 
 
 
 
 
Mean(SD) 
Radial Metaphysis BMC 
Radial Diaphysis BMC 
Total Radius BMC 
FNBMC 
Total Hip BMC 
Femoral Diaphysis 
LSBMC 
 
Protein intake g/d:  
r (not adjusted) 
0.26 
0.21 
0.27 
0.20 
0.18 
0.23 
0.24 
 
Standardized Beta (adjusted for physical 
activity and calcium intakes) 
0.201 
0.120 
0.199 
0.187 
0.122 
0.190 
0.217 
 
 
 
Data for <median physical activity only 
shown:  
Protein>median vs. <median:  
649(82) vs. 663(103) 
919(104) vs. 937(104) 
2679(379) vs. 2807(422) 
1980(321) vs. 1988(321) 
10342(1958) vs. 10535(1973) 
17575(3698) vs. 18431(3486) 
15652(2080) vs. 15839(2505) 
 
P 
 
0.0001 
0.002 
0.0001 
0.002 
0.005 
0.0003 
0.0002 
 
 
 
0.013 
0.146 
0.013 
0.028 
0.136 
0.025 
0.009 
 
 
 
 
 
 
- 
- 
- 
- 
- 
- 
- 
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Chevalley et al. 
2014, Switzerland 
Age 7: 1.8; Age 15: 
1.1 (g/Kg/d) 
High 
resolution 
pQCT 
Adolescent 
boys 
176 Bone outcomes at 15 
years: 
 
FN vBMD 
TotalHipvBMD 
FNBA 
FN width 
FNBMD (DXA) 
TotalHipBMD (DXA) 
DistalTibia Total vBMD 
 
 
 
FN vBMD 
TotalHipvBMD 
FNBA 
FN width 
FNBMD (DXA) 
TotalHipBMD (DXA) 
DistalTibia Total vBMD 
Protein intake at Age 7 years:                        
Higher (n=36) vs lower protein (n=52) 
(lower  physical activity)  
4645±788  vs. 4411±795 
36389±7995 vs. 34381±7493 
5.28±0.50 vs. 5.18±0.47 
3.49±0.33 vs. 3.43±0.31 
879±109 vs. 846±112 
976±127 vs. 937±130 
276±39 vs. 259±44 
 
Higher (n=49) v s lower  protein(n=38)  
(higher  physical activity) 
5075±894 vs. 4405±858 
40913±8451 vs. 35303±7863 
5.46±0.36 vs. 5.26±0.47 
3.61±0.24 vs. 3.48±0.31 
932±139 vs. 834±122 
1011±140 vs. 929±144     
 
 273±41 vs. 263±53 
 
 
0.176 
0.233 
0.341 
0.341 
0.178 
0.169 
0.063 
 
 
 
0.0006 
0.002 
0.030 
0.030 
0.0009 
0.009 
0.336 
Chiu et al, 1997, 
Taiwan   
1.09  DPA 
(BMD) 
Older post F 258  
LSBMD 
FNBMD 
r Protein g/d (unadjusted- Pearson¶s 
values) 
0.107 
0.085 
0.09 
0.18 
Coin et al, Italy, 
2008 
 
75.8+/-22.1 g/d 
Weight=74.2+/-13.4 
 
So  1.02 g/Kg/d 
DXA Males, mean 
age 73.9+/-5.6 
years 
136 Male data only for 
protein (no data for 
females) n=136 
Total Hip BMD 
 
 
FNBMD* chosen for 
pooling men as same as 
other studies 
 
TrochBMD 
R squared 
 
 
0.12(non adj) p<0.001   
0.06(adj) p<0.01             r(adj)=0.25 
 
0.03(nonadj) p<0.05     
0.01(adj) p>0.05             r(adj)=0.1 
 
 
0.10(nonadj)p<0.001 
0.08(adj) p<0.01             r(adj)=0.28 
 
Controlling for 
BMI, albumin, 
skeletal muscle, 
age 
31 
 
 
 
Cooper et al, 
1996, USA 
72g/d DPA/SPA 
(BMD) 
Pre (72) and 
post (218)  F 
290  
 
LSBMD(pre) 
TrochBMD (pre) 
FNBMD(Pre) 
DRBMD (pre) 
MRBMD(pre) 
FSBMD(pre) 
LSBMD(post) 
TrochBMD(post) 
FNBMD(post) 
DRBMD (post) 
MRBMD(post) 
FSBMD(post) 
 
HPO(pre)* 
HPO(post)* 
OC(pre)* 
OC(post)* 
Adjusted for age, weight, physical activity 
 
0.20   adj=0.07 ns 
0.36   adj=0.35 p<0.01 
0.26   adj=0.27 p<0.05 
0.35   adj=0.28 p<0.01 
0.27   adj=0.21 p<0.05 
0.22   adj=0.16 ns 
0.13   adj=-0.05 ns 
0.20   adj= -0.06 ns 
0.25   adj=0.02 ns 
0.19   adj=-0.08 ns 
0.21   adj=-0.05 ns 
0.24   adj=0.01 ns 
* age adjusted: 
-0.25 p<0.01 
-0.01 p>0.05 
0.20 p>0.05 
0.05 p>0.05 
P for unadj data 
Ns 
<0.01 
<0.05 
<0.01 
<0.05 
Ns 
Ns 
<0.01 
<0.001 
<0.01 
<0.01 
<0.001 
Dawson-Hughes  
et al, 2002, USA 
79g/d 
 
DXA 184 men and 
women(>=65 
years old) in 
placebo 
(inactive) arm 
of  calcium 
supplementati
on trial  
184  
 
TBBMD 
 
 
 
FNBMD 
 
 
 
LSBMD 
 
 
 
sOC (nmol/L) 
 
 
uNTX (nmol) 
Tertile protein intake, % of energy 
 
Tertile 1   1.12(0.13) 
Tertile 2   1.10(0.11) 
Tertile 3   1.07(0.14) 
 
Tertile 1  0.89(0.14) 
Tertile2  0.86(0.12) 
Tertile3  0.86(0.14) 
 
Tertile 1  1.17(0.23) 
Tertile2   1.17(0.20) 
Tertile 2  1.11 (0.25) 
 
Tertile 1  1.1(0.3) 
Tertile2   1.1(0.4) 
Tertile3   1.1(0.4) 
 
Tertile 1  231(172) 
Tertile2   218(115 
Tertile3   232(218) 
 
 
 
ns 
 
 
 
ns 
 
 
 
ns 
 
 
 
ns 
 
 
 
ns 
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Devine et al, 2005, 
Australia 
1.2 DXA , 
QUS 
Elderly F 
mean age 
75y+/-3y 
Caucasian  
1077 TP: 
Total Hip BMD 
BUA calcaneus 
 
TP: 
TotalHipBMD 
FNBMD 
TrochBMD 
IntertrochBMD 
BUA calcaneus 
SOS 
Stiffness 
 
 
 
 
 
 
 
 
 
 
 
 
Total Hip BMD 
 
 
Femoral Neck BMD 
 
 
Trochanter BMD 
 
 
Intertrochanter BMD 
r values (unadjusted) 
0.138 
0.136 
 
Unstandardized Beta (SE): 
0.31 (0.07) 
0.26 (0.07) 
0.32 (0.08) 
0.32 (0.06) 
0.02 (0.08) 
Not shown 
0.02 (-0.06) 
 
BUA (db/Hz): 
<66 g/d: 99.6 ± 0.4 (n = 357) 
66-87 g/d: 100.8 ± 0.4 (n = 337) 
>87 g/d: 101.2 ± 0.4 (n = 341) 
 
BMD at Hip Sites (mg/cm2) 
Tertile 1 <66 g/d (n = 374) 
Tertile 2 66-87 g/d (n = 350) 
Tertile 3 >87 g/d (n = 351) 
 
               Mean      SE         95%CI 
Tertile 1  0.798 0.006 0.79,        0.81 
Tertile 2  0.815 0.006 0.80, 0.83 
Tertile 3  0.823 0.006 0.81, 0.84 
Tertile 1  0.679 0.005 0.67, 0.69 
Tertile 2  0.695 0.005 0.69, 0.71 
Tertile 3  0.701 0.005 0.69, 0.71 
Tertile1   0.625 0.005 0.62, 0.64 
Tertile 2  0.640 0.005 0.63, 0.65 
Tertile 3  0.649 0.005 0.64, 0.66 
Tertile 1  0.937 0.007 0.92, 0.95 
Tertile 2  0.957 0.007 0.94, 0.97 
Tertile 3  0.964 0.007 0.95, 0.98 
- 
- 
 
 
 
<0.01 
<0.05 
<0.01 
<0.05 
<0.01 
NS 
NS 
 
Ekbote et al, 
2011, India 
18.6g/d-normal and 
malnourished 
children combined 
DXA 2-3 year old 
children 
71 Normal children: 
TBBMC 
TBBA 
 
 
0.62* 
0.65* 
 
 
<0.01 
<0.01 
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Malnourished Children: 
TBBMC 
TBBA 
 
All children: 
TBBMC 
TBBA 
 
0.44* 
0.57* 
 
 
0.55* 
0.58* 
*remained statistically significant when 
adjusted for energy intake 
 
 
<0.05 
<0.01 
 
 
<0.01 
<0.05 
Fairweather-Tait 
et al, 2011, UK 
81.3g/d DXA Postmenopaus
al female twin 
pairs 
(Monozygotic  
or dizygotic 
twins) 
2464 
pairs 
Energy adjusted  protein 
intake (g): 
 
 
 
LSBMD (n=1232 pairs) 
HipBMD(n=1218 pairs) 
FNBMD (n=1019 pairs) 
 
 
LSBMD (n=1232 pairs) 
HipBMD(n=1218 pairs) 
FNBMD (n=1019 pairs) 
Beta(adjusted for age, BMI, smoking, 
physical activity), 
Including variables for individual diet and 
twin difference: 
 
 0.029 (-0.014, 0.072) 
-0.013 (-0.047, 0.022) 
-0.033 (-0.071, 0.005) 
 
Individual intakes only in model:  
 0.012 (-0.023, 0.046) 
-0.005 (-0.036, 0.025) 
-0.027 (-0.060, 0.005) 
P (adjusted for 
multiple 
comparisons) 
 
0.651 
0.964 
0.365 
 
 
0.502 
0.738 
0.102 
Freudenheim et 
al, 1986, USA 
1.02 SPA Pre and post F, 
35-65y, 
Caucasian 
84 (17 
pre F, 67 
post F) 
 
RBMC (pre)  
HumBMC (pre)  
UBMC (pre) 
 
RBMC (post)  
HumBMC (post)  
UBMC (post) 
 
 
TP 
 
 
 
 
TP 
r, p 
0.384, 0.128 
0.157, 0.546 
0.282, 0.272 
 
-0.017, 0.889 
0.138, 0.267 
0.044, 0.725 
 
Slope of bone loss: 
Pre F: r, p 
RBMD   0.742, 0.022 
HuBMD 0.518, 0.153 
Ulna      0.428, 0.250 
 
Post F: r, p 
RBMD   0.493, 0.004 
HuBMD 0.258, 0.147 
Adjusted for bone 
width 
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Ulna     -0.095, 0.597 
Geinoz et al, 
1993, Switzerland 
Mean Intake in g/d 
by group: 
37.8-59.4 
 
DXA Elderly M and 
F 
Mean age 
82y(F); 80(M) 
74 Gender, protein intake 
 
F,>1g/Kg/d 
FNBMD 
FSBMD 
SpineBMD 
 
F<1g/Kg/d 
FBBMD 
FSBMD 
SpineBMD 
 
M,>1g/Kg/d 
FNBMD 
FSBMD 
SpineBMD 
 
M,<1g/Kg/d 
FNBMD 
FSBMD 
Spine BMD 
Mean +/-SD 
 
 
0.679+/-0.09 
1.288+/-0.35 
0.935+/-0.24 
 
 
0.574+/-0.13 
1.120+/-0.33 
0.877+/-0.36 
 
 
0.761+/-0.12 
1.516+/-0.19 
1.094+/-0.26 
 
 
0.643+/-0.14 
1.318+/-0.34 
0.847+/-0.18 
P 
 
 
Ns 
Ns 
Ns 
 
 
p<0.05 
ns 
ns 
 
 
ns 
ns 
ns 
 
 
p<0.05 
ns 
p<0.05 
Genaro et al, 
2015, Brazil 
66g/d DXA Women over 
65 years old 
200  
 
TBBMCg/cm2 
LSBMD g/cm2 
FNBMD g/cm2 
TrochBMD g/cm2 
Total Femur BMD g/cm2 
 
 
TBBMCg/cm2 
LSBMD g/cm2 
FNBMD g/cm2 
TrochBMD g/cm2 
Total Femur BMD g/cm2 
 
 
TBBMCg/cm2 
LSBMD g/cm2 
Protein:g/Kg/d 
<0.8 (n=73)  
0.988 
0.903 
0.760 
0.679 
0.807 
 
0.8-1.2 (n=84) 
1.025 
0.965 
0.795 
0.689 
0.833 
 
>1.2 (n=43) 
1.039 
0.983 
P for trend: 
 
0.011 
0.014 
0.017 
0.071 
0.026 
 
Posthoc tests: 
>1.2 vs. <0.8 
P<0.05 at all sites 
 
>1.2 vs 0.8-1.2 
P<0.05 for 
TBBMC, 
LSBMD and 
FNBMD 
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FNBMD g/cm2 
TrochBMD g/cm2 
Total Femur BMD g/cm2 
 
 
0.813 
0.727 
0.868 
 
Gregg et al, 1999, 
USA 
0.9 QUS Middle aged 
(premenopaus
al) F- mean 
age= 45.5y 
393  
BUA Calc 
SOS Calc 
LSBMD 
FNBMD 
 
Dietary protein: per 
87kcal 
BUA 
 
 Unadjusted coefficients (non adjusted) 
3.15 
0.96 
0.015 
0.010 
 
Controlling for lean body mass, physical 
activity, race, menopausal status, BMI:  
0.14 SD increase 
 
0.0008 
0.02 
0.02 
0.09 
 
 
 
0.004 
Gunn et al, 2014, 
New  Zealand 
79g/d Bone 
markers, 
DXA 
Postmenopaus
al women, 60 
years of age 
142  
 
FNBMD 
FN T-Score 
sCTX 
sP1NP 
Energy adjusted protein: (not adjusted for 
other confounders) 
0.19 
 0.17 
-0.18 
-0.23 
 
 
<0.05 
<0.05 
<0.05 
<0.05 
Hannan et al. 
2000, USA 
68g/d (16% of total 
energy) 0.97 g/kg/d 
DXA Older men and 
women  
615 TP 
 
FNBMD 
QI 
Q4 
  
TrochBMD 
Q1 
Q4 
 
Wards BMD 
Q1 
Q4 
 
LSBMD 
Q1 
Q4 
 
RBMD 
Change in BMD by protein quartile: 
 
 
-4.61 +/- 070* 
-2.32 +/-0.74 
 
 
-8.00 +/- 0.84 
-6.65+/-0.90 
 
 
-7.05+/-1.0 
-4.39+/-1.1 
 
 
-3.72+/-0.97 
-1.11+/-1.1 
 
 
*= p<0.05  Q1 
compared with 
Q4 
 
Adjusted for total 
energy intake, 
age, sex, weight, 
weight change, 
height, alcohol 
intake and 
smoking (current 
or former). 
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Q1 
Q4 
 
AP 
 
FNBMD 
QI 
Q4 
  
TrochBMD 
Q1 
Q4 
 
Wards BMD 
Q1 
Q4 
 
LSBMD 
Q1 
Q4 
 
RBMD 
Q1 
Q4 
-4.21+/-0.71 
-4.31+-0.76 
 
 
 
 
-3.95 +/- 0.69* 
-2.15+/-0.73 
 
 
-2.57+/-0.86 
-1.95+/-0.92 
 
 
-4.02+/-1.0 
-1.97+/-1.1 
 
 
-3.79+/-0.99 
-1.65+/-1.1 
 
 
-4.60+/-0.71 
-4.52+/-0.76 
Henderson et al, 
1995 , Australia 
1.0 DXA Pre F- mean 
age=18y 
115  
FNBMD 
IntertrochBMD 
TrochBMD 
DTB BMD 
TFBMD 
FSBMD 
LSBMD 
Unadjusted r values 
0.22 
0.19 
0.27 
0.05 
0.21 
0.09 
0.05 
 
p<0.05 
p<0.05 
p<0.005 
p>0.05 
p<0.05 
p>0.05 
p>0.05 
Hernandez et al, 
1993, USA 
76g/d SPA Pre- and 
Perimenopaus
al Women 
(50-60 years 
old) 
281 Ultradistal R BMD Beta=0.0108 SE=0.259 (unstandardized 
beta)  
Adjusted for dietary nutrients, alcohol and 
caffeine. 
NS  
Hirota et al, 1992, 
Japan 
1.13  SPA 
(BMD) 
Young pre F: 
19-25y 
161 Forearm BMD 
 
 
r=0.0017 (adjusted for sports, BMI, milk 
intake in childhood, dieting, skipping 
meals) 
0.03 
Adjusted for 
sports, BMI, 
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Dietary intakes g/d by Forearm BMD 
category (BMD % of mean) 
<=85%      50.7+/-13.6 
86-100%   56.8+/-13.3 
101-114% 60.1+/-18.2* 
>=115%     64.2+/-19.7* 
*significantly different from the <=85% 
group (lowest) 
 
childhood milk 
intake, dieting, 
skipping meals 
Ho et al, 2003, 
China Soy 
protein 
1.01 SP DXA <12y post  
F(48-62y), 
Asian 
454  
(269 <4 
y post F  
185  >4 y 
post F) 
ALL WOMEN 
 
 
Spine BMD  
FNBMD 
TrochBMD 
IntertrochBMD 
TotalHipBMD 
TBBMD 
TBBMC 
 
 
Spine BMD  
FNBMD 
TrochBMD 
IntertrochBMD 
TotalHipBMD 
TBBMD 
TBBMC 
Quartile of soy protein intake: 
 
Q1                      Q4 
0.825±0.118      0.844±0.133 
0.668±0.103      0.694±0.099 
0.581±0.098*     0.606±0.095 
0.945±0.145*     0.981±0.130 
0.781±0.118*     0.815±0.111 
0.958±0.088      0.966±0.084 
1601±255          1649±228 
 
 
Standardized beta (SE) 
0.0034(0.005)    
0.0048(0.004) 
0.0056(0.004) 
0.0069(0.005) 
0.0070(0.004) 
0.0071(0.004) 
5.974   (8.784) 
 
Controlling for soy protein intake quartile, 
weight, years since menopause, calcium  
intake quartile, soy protein- calcium 
interaction, total protein intake, and energy 
intake 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.497 
0.200 
0.119 
0.162 
0.087 
0.842 
0.497 
Ho et al, 2008, 
China 
5.2g/d SP 
48.6 g/d TP 
DXA Pre and 
perimenopaus
438   
 
r(adj)=adjusted for age-menopause stage 
and energy  intake 
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al women 45-
55 years old 
TP: 
LSBMD 
 
FNBMD 
 
TotalHipBMC 
 
WBBMC 
 
 
SP: 
LSBMD 
 
FNBMD 
 
TotalHipBMC 
 
WBBMC 
 
 
 
Quartile of soy protein 
intake: 
WBBMC 
 
 
 
 
Change from baseline: 
(30 months) 
TBBMC 
 
Q1 <1.07 g/d Reference 
Q2 1.07-2.84  g/d 
Q3 2.85-5.72 g/d 
Q4 >5.72 g/d 
 
r=0.064 
r(adj)=0.016 
r=0.088 
r(adj)=0.037 
r=0.084 
r(adj)=0.053 
r=0.075 
r(adj)=0.024 
 
 
r= -0.043 
r(adj)= -0.05 
r=0.020 
r(adj)= -0.004 
r= -0.001 
r(adj)= -0.027 
r= -0.002 
r(adj)= -0.017 
 
 
Standardized beta (SE) 
Q1(<1.07)=Reference 
Q2(1.07-)=0.19 (0.3282) 
Q3(2.85-)=0.73 (0.3340) 
Q4(5.72+)=0.73 (0.3225) 
 
 
Quartile of soy protein intake vs TBBMC: 
Unst. Beta*     SE 
               
 
1.0000 
0.1932     0.3282 
0.7306   0.3340 
0.7303     0.3225 
*Controlling for baseline BMC, lean mass, 
change in weight, number of pregnancies, 
walking and menopausal status. 
 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
 
 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
 
 
 
- 
ns 
<0.05 
<0.05 
 
 
 
 
 
 
 
ns 
<0.05 
<0.05 
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Ho-Pham et al, 
2009, Vietnam 
g/d: 
TP= 35.4(11.6) 
Vegans, 62.6(18.3) 
Omnivores 
 
AP=2.1(3.2) 
Vegans, 34.6(15.8) 
Omnivores 
 
VP=33.2(11.6)Vega
ns, 28.0(8.4) 
Omnivores 
DXA 105 Post F 
Buddhist 
vegan Nuns 
and 105 
omnivorous 
women 62+/-
10 years old 
210   
FNBMD 
LSBMD 
TBBMD 
 
 
FNBMD 
LSBMD 
TBBMD 
 
AP: +10g Beta 
0.008 (0.006) 
0.013 (0.008) 
0.006 (0.006) 
 
VP:+10g Beta 
-0.008 (0.007) 
 0.014 (0.009) 
-0.014(0.006) 
 
0.175 
0.108 
0.313 
 
 
0.261 
0.128 
0.033 
Ho-Pham et al, 
2012, Vietnam 
TP: 
36g/d Vegans 
62g/d Omnivores 
DXA 105 Buddhist 
vegan Nuns 
and 105 
omnivorous 
women 
Mean(SD) age 
61(9.2) 
181  
Change in:  
LSBMD 
FNBMD 
Beta: (adjusted for age, anthropometry, fat 
intake) 
VP: -0.075(0.035) 
AP:VP ratio: -0.244 (0.094) 
 
 
0.036 
0.01 
Hoppe  et al. 
2000,  Denmark 
82g/d (Boys) 
73g/d(Girls) 
DXA 10 year old 
children 
105 WBBMC 
WBBA 
0.327  (unadjusted r values) 
0.311 
Has linear regression but only p values, not 
effect size p1027 
<0.001 
<0.01 
Horiuchi et al, 
2000, Japan 
Total- 62.5g/d 
Soy-12.6g/d 
DXA Post F, 52-83y 85 Soy 
LSBMD 
Osteocalcin 
ALP 
Pyridinoline 
Deoxypyd 
Total Protein 
LSBMD 
Pyridinoline 
Deoxypyd 
Osteocalcin  
ALP 
 
Z score for LSBMD 
Total protein 
Soy protein 
r values (unadjusted) 
0.251  
-0.097  
-0.017 
-0.132 
-0.229 
 
0.223  
-0.229 
-0.218 
-0.131 
-0.09 
 
Beta (standardized): 
-0.03 (no SE or p value given)* used in SR  
0.225 (no SE given) 
 
p<0.05 
ns 
ns 
ns 
p<0.05 
 
p<0.05 
p<0.05 
ns 
ns 
ns 
 
 
ns 
0.038 
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Hu et al, 2014,  
USA 
TP: 12.0-19.0 % 
energy intake (F) 
TP: 11.6-20.4% 
energy intake (M) 
QCT 801 women 
and 857 men 
enrolled on the 
Multi-Ethnic 
Study of 
Atherosclerosi
s (age 62+/-10 
years) 
1658  
LS vBMDmg/cm3  n1658 
 
 
 
 
LSBMD ZScore: n801 
TP: 
White 
Chinese 
Black 
Hispanic 
 
AP: 
White 
Chinese 
Black 
Hispanic 
 
VP: 
White 
Chinese 
Black 
Hispanic 
 
 
 
 
 
 
 
 
 
 
 
LS trabecular vBMD 
Female, AP 
White 
Chinese 
Black 
Quartile of protein intake: 
Q1  115+/-40 
Q2  115+/-38 
Q3  116+/-42 
Q4  112+/-39 
 
Standardized Beta, p 
     
-0.06 0.75 
-0.07 0.84 
0.35 0.2 
0.16 0.55 
 
 
-0.13 0.51 
-0.65 0.06 
0.29 0.37 
0.40 0.16 
 
 
0.44 0.02 
0.22 0.49 
-0.36 0.27 
0.06 0.9 
 
Model adjusted for age, BMI, physical 
activity, sedentariness, smoking, 
education, hormone therapy use, age at 
menopause, and intakes of total 
energy, dietary carbohydrate as a 
percentage of energy, Ca, P, Mg and 
alcohol. 
 
Quartiles of protein intake: Q4 mean (96% 
CI) 
 
97.3 (87.7, 106.8) 
107.5 (68.0, 146.9) 
134.9 (117.3, 152.4) 
120.5 (105.2, 135.8) 
 
 
 
 
P=0.88 
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Hispanic 
 
Male AP 
White 
Chinese 
Black 
Hispanic 
 
Female, VP 
White 
Chinese 
Black 
Hispanic 
 
Male VP 
White 
Chinese 
Black 
Hispanic 
 
 
110.3 (100.8, 119.7) 
115.9 (99.5, 132.2) 
155.7 (135.3, 176.1) 
128.8 (117.3, 140.3) 
 
 
 107.4 (98.6, 116.2) 
139.4 (102.5, 176.2) 
125.8 (110.3, 141.4) 
112.8 (100.5, 125.2) 
 
 
105.0 (97.1, 112.9) 
109.6 (94.8, 124.4) 
141.6 (122.9, 160.3) 
123.6 (112.6, 134.6) 
Ilich et al, 2003, 
USA 
1.04 DXA Older F, >5 
post, 
Caucasian, 
mean age 
68.7+/-7.1y 
136  
 
 
 
 
 
TBBMD 
TBBMC 
WBMD 
HBMD 
Unstandardized. Beta (adjusted for age, 
lean body mass, total body fat, and height 
(in TBBMC model), past physical activity, 
present mode of walking, and energy 
intake 
 
1 x10-3 (also adjusted for Ca intake) 
2.9 
1.4x10-3 (also adj for ca and vit C intake) 
4.1x10-4 (also adjusted for ca intake) 
 
 
 
 
 
 
0.027 
0.03 
0.021 
0.021 
Iuliano-Burns et 
al, 2005, 
Australia 
76g/d  
 
DXA 7-20 year old 
Male twins 
(Monozygotic 
n=30) and 
Dizygotic 
(n=26)  
56  
 
 
TBBMC (g) 
Arm BMC (g) 
Leg BMC (g) 
LSBMC (g) 
Beta coefficient: Within pair difference in 
protein intake, adjusted for anthropometric 
and lifestyle factors. 
1.3 
0.7 
0.3 
0.0 
 
 
 
ns 
<0.05 
ns 
ns 
Jaime et al, 2006, 
Brazil 
1.2  DXA  Men- Over 
50y 
277 
(n=31 
Black 
and 
 
 
FNBMD (Black) 
FNBMD (White) 
Energy adjusted protein intake (not 
adjusted for other confounders) 
0.359 
0.055 
 
 
0.040 
0.505 
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n=246 
white) 
 
 
FNBMD(black) 
FNBMD (white) 
 
 
Beta: (Unadjusted, standardized.) 
0.00192 
0.00058  
 
 
0.261 
0.299 
Jones et al. 2001, 
Tasmania 
83g/d DXA Boys and Girls 
Aged 8 years 
old 
330  
(n=262 
in 
analysis) 
 
FNBMD 
LSBMD 
TBBMD 
Non adjusted r values: 
-0.05 
 0.00 
-0.09 
 
>0.05 
>0.05 
>0.05 
Knurick et al. 
2015, USA 
Omnivore: 97g/d 
Lacto-ovo 
Vegetarian: 68g/d 
Vegan: 69g/d 
DXA Adult men and 
women, 18-50 
y (combined 
data only) 
81 TBBMD, TP 
All 
Omnivores 
Lacto-ovo Vegetarian 
Vegans 
 
Pearson¶s correlations (unadjusted): 
0.274- used in TBBMD pooling 
0.190 
0.262 
0.434 
 
0.017 
ns 
ns 
<0.05 
Kumar et al, 
2010, Northern  
India 
45.7g/d DXA Women aged 
20-69 years 
225  
LSBMD 
FNBMD 
WardsBMD 
 
 
LSBMD 
FNBMD 
WardsBMD 
 
Dietary protein: (non-adjusted r values) 
 0.224 
 0.040 
-0.039 
 
Q1, Q4 (Mean, SD) 
1.05(0.20), 1.15(0.18) 
0.96(0.20), 0.93(0.15) 
0.87(0.27), 0.80(0.18) 
 
0.0001 
0.529 
0.536 
 
 
- 
- 
- 
 
Lacey et al, 1991, 
Japan 
1.35 SPA Asian pre 
F(35-40y) and 
post F (55-
60y) 
178 (89 
pre F, 89 
post F) 
MRBMC 
PreF 
Post F 
% protein in diet vs. radial BMC 
0.22 
0.19 
Adjusted for age, BMI, energy  intake 
 
0.04   
0.05  
Langsetmo et al., 
2015 Canada 
0.79g/Kg/d  DXA Men and 
women aged 
over 25 years 
old 
6510 (n not given for 
subgroups) 
 
Men 25-49 y   
Hip BMD  
HipBMD change:  
LSBMD  
LSBMD change:  
 
Premenopausal Women 
25-49 y  
AP (Non-dairy) 
Beta (95%CI) 
 
 
-0.001 -0.016, 0.013 
 0.000 -0.004, 0.004 
-0.012 -0.026, 0.003 
-0.001 -0.006, 0.005 
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Hip BMD  
HipBMD change:  
LSBMD  
LSBMD change: 
 
Men 50+ y  
Hip BMD  
HipBMD change:  
LSBMD  
LSBMD change: 
 
Postmenopausal Women 
50+ y  
Hip BMD  
HipBMD change:  
LSBMD  
LSBMD change: 
 
Men 25-49 y  
Hip BMD  
HipBMD change:  
LSBMD  
LSBMD change:  
 
Premenopausal Women 
25-49  
Hip BMD  
HipBMD change:  
LSBMD  
LSBMD change:  
 
Men 50+  
Hip BMD  
HipBMD change:  
LSBMD  
LSBMD change:  
 
Postmenopausal Women 
50+ y  
Hip BMD  
-0.004 -0.015, 0.006 
 0.001 -0.002, 0.005  
-0.012* -0.024, 0.000     
 0.001 -0.005, 0.003 
 
 
-0.002 -0.011, 0.006  
 0.001 -0.001, 0.004  
 0.000 -0.011, 0.011  
 0.000 -0.003, 0.004 
 
 
 
0.004 -0.001, 0.009  
0.000 -0.002, 0.002  
0.010* 0.003, 0.016  
0.001 -0.001, 0.003 
 
  
-0.010 -0.024, 0.003  
 0.001 -0.003, 0.005 
 -0.013 -0.027, 0.001  
 0.000 -0.005, 0.005 
 
 
 
-0.011* -0.022, -0.001 
-0.003 -0.006, 0.001  
-0.005 -0.017, 0.007  
-0.002 -0.006, 0.003 
 
 
-0.007 -0.016, 0.001  
  0.001 -0.002, 0.003 
 -0.009 -0.020, 0.002   
  0.001 -0.002, 0.005 
 
 
-0.006* -0.011, -0.001   
 0.000 -0.002, 0.002  
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HipBMD change:  
LSBMD  
LSBMD change:  
-0.012* -0.019, -0.005  
-0.003* -0.005, 0.000 
 
*=CI indicates exclusion of null effect 
 
Lau et al, 1998, 
China 
0.65  (vegetarians) DXA  Post F, 70-89y 76   
LSBMD 
FNBMD 
IntertrochBMD 
WBMD 
 
 
 
 
LSBMD 
FNBMD 
IntertrochBMD 
WBMD 
 
Unadjusted r values 
0.09 
0.13 
0.084 
0.042 
 
Beta coefficient- adjusted for energy 
intake, age, calcium intake, urinary Na:Cr 
ratio 
7.9x10-4 
-6.8x10-4 
-3.6x10-3 
-1.0x10-3 
-  
- 
- 
- 
 
 
 
 
 
>0.05 
>0.05 
>0.05 
>0.05 
Libuda et al. 
2008, Germany 
1.3 g/Kg/d pQCT Children and 
adolescents 8-
14 years old 
228  
 
BMC 
Cortical Area: 
PC: 
SSI: 
Standardized (Beta) coefficient: Total 
Protein 
1.02 
0.97 
0.28 
5.23 
 
 
 
0.03 
0.01 
0.02 
0.01 
Libuda et al. 
2011, Germany 
Median protein: 
 
Boys: 46.1g/d 
Girls: 42.7g/d 
pQCT Pre-pubertal 
children 
107 
(N=57 
Boys 
N=50 
Girls) 
Diaphyseal bone 
Forearm : 
 
vBMC mg/mm 
 
Cortical Area mm2 
Coefficients: Controlling for muscle area 
and androstenediol 
 
Beta=1.49 
Beta (stand)=0.11 
Beta=1.37 
Beta(stand)=0.11 
 
 
 
0.073 
 
 
0.056 
Loenekke et al. 
2010,  USA 
91.3+/- 45.15 g/d 
 
71.72 +/- 13.95 kg 
DXA Males and 
Females, 
22+/-3 years 
27  
TBBMD 
TBBMC 
r values, controlling for body mass: 
0.607 
0.557 
 
0.001 
0.003 
MacDonald et al, 
2005, UK 
 
 
79.4g/d Bone 
Markers, 
DXA 
45-54y 
women, pre, 
peri or post 
menopausal 
5119  
DPD/Cr n=2929 
 
 
Mean (g/d) by Quartile (Q) 
Q1 69.0 
Q2 76.4 
Q3 84.3 
ANCOVA: 
(confounder 
adjusted)  
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PYD/Cr n=2929 
LSBMD n=3226 
FNBMD n=3226 
Q4 99.3 
Data not shown 
Data not shown 
Data not shown 
P=0.02 
P=0.01 
ns 
ns 
Meng et al. 2009 
Australia 
80.6g/d DXA 862 elderly 
women 75 ± 3 
(SD) yr of age 
of white 
origin. 
862 TBBMC 
 
 
 
TBBMC 
AppendicularBMC 
 
 
TBBMC 
AppendicularBMC 
 
 
TBBMC 
AppendicularBMC 
r=0.15  
Unadjusted correlation between baseline 
protein intake and 5 year BMC 
 
Q1 n=287, <66g/d 
1352±236 1 
388±242 
 
Q2 n=287, 66-87g/d 
1433±262 
888±162 
 
Q3 n=288, >87g/d 
918±164 
942±177 
 
Whole body BMC (mg/cm2, headless) 
<66 g/d: 1357 ± 17 (n = 287) 
66-87 g/d: 1387 ± 13 (n = 287) 
>87 g/d: 1429 ± 18 (n = 288) 
  
Appendicular BMC (mg/cm2) 
<66 g/d: 889 ± 11 (n = 287) 
66-87 g/d: 917 ± 9 (n = 287) 
>87 g/d: 942 ± 12 (n = 288) 
<0.001 
 
 
 
Metz et al, 1993, 
USA 
1.24 SPA Pre F 
Caucasian 
(24-28y) 
38  
 
DRBMC 
DRBMD 
MRBMC 
MRBMD 
Unstandardized B (SEM) adjusted for 
calcium intake, physical activity, lean 
body mass 
-0.450 (0.183) 
-0.434 (0.194) 
-0.503 (0.180) 
-0.251(0.214) 
 
 
 
0.019 
0.032 
0.009 
0.248 
Michaelsson et al, 
1995, Sweden 
59g/d DXA 
(Dietary 
Records 
F 28-74y, 
Caucasian 
175  
 
 
Standardized Beta (adjusted for BMI, 
energy intake, physical activity,  
menopausal status, menopausal age, 
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data used, 
not FFQ) 
 
 
 
 
TBBMD 
LSBMD 
FNBMD 
 
 
TBBMD 
LSBMD 
FNBMD 
 
 
 
TBBMD 
LSBMD 
FNBMD 
OC 
smoking, diabetes, cortisone, HRT, athletic 
activity 
 
Dietary records 
0.00086 
-0.0010 
0.0028 
 
Food frequency records: 
0.0020 
0.0013 
0.0024 
 
 
Unadjusted r values: 
0.189 
0.058 
0.117 
-0.036 
 
 
 
 
0.28 
0.51 
0.04 
 
 
0.005 
0.36 
0.06 
 
 
 
0.018 
0.474 
0.151 
0.669 
Nakamura et al, 
2004, Japan 
1.29 Bone 
markers 
Elderly post F, 
mean 
age=68.3y , 
range 43-79 
43  
OC 
Bone ALP 
Deoxypyd. 
NTX 
 
Unadjusted r values: 
-0.197  
-0.039  
-0.241  
-0.205  
 
p>0.05 
p>0.05 
p>0.05 
p>0.05 
Neville et al, 2002, 
UK 
98g/d (M) and 
66g/d(F) 
DXA 238 M and 
205 F, at both 
15 and 20-25 
years of age 
443 Young adult (20-25y old) 
BMD: 
 
MALES: 
LSBMD 
FNBMD 
 
FEMALES: 
LSBMD 
FNBMD 
 
 
Young adult (20-25y old) 
BMD: 
 
Standardized Beta(adjusted for dietary, 
anthropometric  and lifestyle parameters): 
 
Young adult protein intake: 
-0.62 
-0.57 
 
Young adult protein intake: 
-0.11 
-0.04 
 
 
Standardized Beta(adjusted for dietary, 
anthropometric  and lifestyle parameters) 
 
 
 
 
 
0.13 
0.16 
 
 
0.61 
0.87 
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MALES: 
LSBMD 
FNBMD 
 
 
FEMALES: 
LSBMD 
FNBMD 
 
Adolescent  protein intake: 
 0.53 
-0.08 
 
 
Adolescent  protein intake: 
0.12 
0.47 
 
 
0.13 
0.83 
 
 
 
0.76 
0.27 
 
New  et al, 1997, 
UK 
81+/-22 g/d DXA Women aged 
44-50 years 
(Premenopaus
al) 
994  
LSBMD 
FNBMD 
TrochBMD 
WardsBMD 
Energy adjusted protein intake 
0.03 
0.02 
0.04 
0.02: 
 
 
P>0.05 ns 
P>0.05 ns 
P>0.05 ns 
P>0.05 ns 
Oh et al, 2013, 
Korea 
TP 
52.3g/d (Men) 
45.0g/d(Women) 
AP 
15.8g/d(Men) 
12.0g/d(Women) 
SP 
3.1g/d(Men) 
2.8g/d(Women) 
VP 
35.5g/d(Men) 
32.2g/d(Women) 
Ultrasound
Calcaneal 
bone 
density 
(stiffness 
index only) 
Men and 
Postmenopaus
al Women 
aged 50-70 
years 
3330 
(2575 in 
analysis) 
 
 
Bone Stiffness 
 
 
 
 
 
 
 
Spearmans Rho (Adjusted for age, energy 
intake, BMI, alcohol, smoking, HRT use, 
exercise, calcium intake): 
 
Men: 
TP 0.027 
AP 0.044 
VP -0.026 
SP -0.013 
VP:AP ratio -0.036 
 
Women: 
TP 0.030 
AP 0.035 
VP -0.012 
SP -0.014 
VP:AP ratio -0.027 
 
 
 
 
 
0.347 
0.136 
0.379 
0.656 
0.220 
 
0.257 
0.195 
0.657 
0.592 
0.318 
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Orozco et al, 
1998,  
Spain 
TP: 73.4(17.9) g/d 
AP: 49.7(15.3)g/d 
VP: 23.7(8.7)g/d 
DXA Premenopausa
l women aged 
42years old 
76  
LS BMD 
FN BMD 
TrochBMD 
IntertrochBMD 
WardsBMD 
 
Normal (n=64) vs. 
Osteopenic (n=12): 
LSBMD 
 
Normal (n=64) vs. 
Osteopenic (n=10): 
TotalHipBMD 
Unadjusted r values 
-0.03 
-0.03 
-0.04* chosen for troch-intertroch analysis 
-0.08 
-0.05 
 
73.5(18.1) g/d vs. 72.8(17.4)g/d 
 
 
 
72.8(18.4)g/d vs 77.0(17.7)g/d 
 
ns 
ns 
ns 
ns 
ns 
 
0.9 
 
 
 
0.5 
Orwoll et al, 
1987, USA 
- CT 
(vertebrae)
, SPA 
(radius) 
Study 1: Men 
 
Study 2: Men 
30-90y 
62 
 
 
92 
 
PRBMC- 1 
DRBMC- 1 
Vertebral BMC-1 
DRBMC- 2 
PRBMC-  2 
Vertebral BMC-2 
Unadjusted r values: 
0.20 
0.03 *chosen for radius pooled analysis 
0.27 * chosen for men BMC analysis 
0.22* chosen for radius pooled analysis 
0.15 
0.30*chosen for men BMC analysis 
 
Ns 
Ns 
<0.05 
Ns 
Ns 
<0.01 
Pearce et al. 2010, 
UK 
Median: 87.7g/d Bone 
Markers 
Men aged 49-
52 years 
412 sCTX r (95% CI) 0.04 (0.001, 0.1)     
Unadjusted linear regression coefficient, 
daily protein intake (per 100g) 
0.04 
Promislow et al, 
2002 USA 
72.5g/d DXA M/F 55-92y 
572F 
388M 
960  
 
 
 
 
 
 
TP: per 15g 
THBMD(F) 
FNBMD(F) 
TotalSpineBMD(F) 
TBBMD(F) 
 
THBMD(M) 
FNBMD(M) 
TotalSpineBMD(M) 
Standardized Beta coefficients (95% CI) 
Controlling for age, body mass index, 
calcium intake, years menopausal (women 
only), diabetes status, current exercise, and 
current use of estrogen (women only), 
steroids, cigarettes, alcohol, thiazides, and 
thyroid hormones 
 
0.0094  (-0.0025, 0.0214) 
0.0063  (-0.0039, 0.0165) 
0.0084  (-0.0090, 0.0258) 
0.0081  (-0.0017, 0.0179) 
 
-0.0003 (-0.0180, 0.0174) 
-0.0045 (-0.0202, 0.0112) 
-0.0095 (-0.0345, 0.0155) 
 
 
 
 
 
 
 
 
0.12 
0.22 
0.34 
0.11 
 
0.97 
0.57 
0.45 
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TBBMD(M) 
 
AP: per 15g 
THBMD(F) 
FNBMD(F) 
TotalSpineBMD(F) 
TBBMD(F) 
 
THBMD(M) 
FNBMD(M) 
TotalSpineBMD(M) 
TBBMD(M) 
 
VP: per 5g 
THBMD(F) 
FNBMD(F) 
TotalSpineBMD(F) 
TBBMD(F) 
 
THBMD(M) 
FNBMD(M) 
TotalSpineBMD(M) 
TBBMD(M) 
 
-0.0078 (-0.0212, 0.0057) 
 
 
0.0162 (0.0049, 0.0275) 
0.0115 (0.0019, 0.0211) 
0.0149 (-0.0016, 0.0314) 
0.0098 (0.0005, 0.0191) 
 
0.0059(-0.0112,0.0230) 
0.0007 (-0.0145,0.0159) 
-0.0007(-0.0249,0.0235) 
-0.0036(-0.0167,0.0095) 
 
 
-0.0133 (-0.0219, -0.0047) 
-0.0102(-0.0175, -0.0028) 
-0.0129 (-0.0255, -0.0003) 
-0.0047 (-0.0121, 0.0026) 
 
-0.0206(-0.0357,-0.0054) 
-0.0131 (-0.0267, 0.0006) 
-0.0327(-0.0542,-0.0112) 
0.0124  (-0.0243,-0.0004) 
0.26 
 
 
0.005 
0.02 
0.08 
0.04 
 
0.50 
0.93 
0.96 
0.59 
 
 
0.002 
0.01 
0.04 
0.20 
 
0.01 
0.06 
0.003 
0.04 
Quintas et al, 
2003, Spain 
 
1.4g-1.7 DPA Pre F 164  
RBMC 
RBMD 
LSBMC 
HipBMC 
LSBMD 
HipBMD 
Unadjusted r values 
0.236 
0.070 
0.434 
0.412 
0.317 
0.301 
 
P<0.05 
ns 
p<0.05 
<0.05 
<0.05 
<0.05 
Rapuri et al, 
2003, USA 
53.7-71.2 
 
 
DXA Post F- 
 65-77y 
473  
MRBMD 
FNBMD 
TrochBMD 
TFBMD 
LSBMD 
TBBMD 
NTX 
OC 
r values: 
0.097 
0.092 
0.155 
0.136 
0.065 
0.129 
-0.022 
0.01 
 
0.036 
0.047 
0.001 
0.003 
0.163 
0.005 
0.641 
0.832 
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Baseline: 
OC ( g/L) 
 
 
 
NTX:Cr ratio 
 
 
 
 
 
 Protein tertile data: 
4.07±0.012   Q1 
3.74±0.012   Q2 
3.81±0.012   Q3 
3.57±0.012   Q4   
56.2±2.45     Q1 
51.82±2.45   Q2 
50.56±2.47   Q3     
44.35±2.46   Q4  
 
 
0.50 
 
 
 
0.50 
 
 
Rubinacci et al, 
1992, Italy 
Recent menopause 
(less than 9 years 
ago, median age 
51y)- 83+/-21.7 g/d 
 
Distant menopause 
(more than 15 years 
ago, median age 
68y) - 68+/-17.6 g/d 
SPA  Post F  120  
Total Protein Intake: 
DRBMC  
DRBMC/BW 
Ultradistal RBMC  
 
 
DRBMC  
DRBMC/BW 
Ultradistal RBMC 
N=81, recent menopause, unadjusted r 
values 
0.305* used for pooling 
-0.062 
0.281 
 
N=39 distant menopause, unadjusted r 
values 
0.041 * used for pooling 
-0.031 
-0.111 
 
<0.001 
ns 
<0.05 
 
 
ns 
ns 
ns 
Sahni et al. 2013, 
USA 
81g/d (Men) 
77g/d (Women) 
 
 
DXA 1,280 men and 
1,639 women 
2919  
 
 
 
 
 
 
 
 
 
 
 
 
 
Cross sectional data: 
FNBMD  
TrochBMD 
LSBMD 
Model 2- adjusted for energy intake, age, 
height, weight, dietary vitamin D intake 
(IU/d), vitamin D supplement use (yes/no), 
Ca supplement use (yes/no), dietary Ca 
intake 
(,800 mg/d or $800 mg), current smoking 
(yes/no), menopausal status (yes/no), 
current oestrogen use (yes/no) in women 
alone, caffeine intake (g/d), 
Physical Activity Scale in the Elderly 
(PASE), osteoporosis medication use 
(yes/no) and alcohol intake (none, 
moderate and heavy intake 
 
Standardized coefficients: 
MEN (N=1268): 
Beta (SE)=0.00115 (0.001) 
Beta(SE)=0.00129 (0.001) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.31 
0.28 
0.72 
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FNBMD  
TrochBMD 
LSBMD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bone change data: 
FNBMD  
TrochBMD 
LSBMD 
 
 
 
FNBMD  
TrochBMD 
LSBMD 
 
Beta(SE)=0.00065 (0.001) 
 
 
WOMEN (N=1614): 
Beta (SE)=0.00185 (0.001) 
Beta(SE)=0.00200(0.001) 
Beta(SE)=0.00280 (0.001) 
 
 
Model 2- adjusted for energy intake, age, 
height, weight, dietary vitamin D intake 
(IU/d), vitamin D supplement use (yes/no), 
Ca supplement use (yes/no), dietary Ca 
intake 
(,800 mg/d or $800 mg), current smoking 
(yes/no), menopausal status (yes/no), 
current oestrogen use (yes/no) in women 
alone, caffeine intake (g/d), 
Physical Activity Scale in the Elderly 
(PASE), osteoporosis medication use 
(yes/no) and alcohol intake (none, 
moderate and heavy intake). 
 
Beta(SE) 
 
MEN (N=493): 
Beta (SE)=-0.0052(0.019) 
Beta(SE)=-0.0498 (0.020) 
Beta(SE)=-0.0062(0.019) 
 
 
WOMEN (N=673): 
Beta (SE)=-0.0131(0.017) 
Beta(SE)=-0.0288(0.21) 
Beta(SE)=0.0042 (0.018) 
 
 
 
 
0.04 
0.02 
0.04 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.78 
0.01 
0.75 
 
 
 
0.44 
0.21 
0.81 
Tanaka et al, 
2001, Japan 
1.3 Ultrasonic 
Bone 
Absorptio
metry 
Pre F-  
18-22y 
965  
 
 
 
Regression B (Unstandardized) 
Coefficient, adjusted for age, weight, 
height, exercise, menstrual 
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OSI calcaneus 
status and daily nutrient intakes (energy, 
Ca, Phosphorus, Sodium) 
0.234 
 
0.009 
Teegarden et al, 
1998, USA 
1.21  DXA  Young pre F 215  
TBBMD 
RBMD 
LSBMD 
FNBMD 
TrochBMD 
WBMD 
TBBMC 
RBMC 
Spine BMC 
 
 
 
TBBMD 
TBBMC 
SpineBMD 
SpineBMC 
Unadjusted r values: 
0.11 
0.16 
0.19 
0.08 
0.10 
0.08 
0.12 
0.08 
0.23 
 
Unstandardized B (SE) adjusted for 
postmenarchal age, lean and fat mass,: 
0.0016+/-0.0006 
6.95+/-2.09 
0.0029+/-0.0013 
0.1823+/-0.068 
 
Ns 
<0.05 
<0.05 
Ns 
Ns 
Ns 
Ns 
Ns 
<0.05 
 
 
 
<0.05 
<0.05 
<0.05 
<0.05 
Thorpe et al, 
2008, USA 
74.7g/d DXA Postmenopaus
al women 
mean age 
68+/-6 years 
161 LSBMD 
TotalHipBMD 
(non adjusted, 
Spearmans) 
 
LSBMD 
-0.01 
0.08 
 
 
Unstandardized correlation coefficient: 
B(SE): controlling for body weight and 
sulphur intake 
1.35x10-3  (6x10-4) 
0.94 
0.30 
 
 
 
 
0.04 
Tylavsky and 
Anderson, 1988, 
USA 
1.01 
 
SPA 60-98y elderly 
F 
375   
DRBMC 
DRBMD 
MRBMC 
MRBMD 
 
2.72 
0.63 
2.96  
1.36 
 
0.03 
0.25 
0.003 
0.06 
Vatanparast et al, 
2007, Canada 
20-25 years: 68+/-
22(F) and 119+/-53 
(M) 
 
Periadolescence: 
64.2+/-17 (F) and 
79.6+/-17 (M) 
DXA Young adults 
(59 males, 74 
females). 
Measured at 
both 
periadolesence 
and young 
133  
 
 
 
 
TBBMC 
TBBMD 
Unstandardized Beta+/-SE (adjusted for 
sex, current height and weight, physical 
activity level, and other dietary nutrients) 
 
Current protein intake (young adult) 
NS (not entered into stepwise model) 
NS (not entered into stepwise model) 
 
 
 
 
 
ns 
ns 
53 
 
 
 
adulthood (20-
25 y) 
TBBMC net gain 
 
 
 
 
 
 
 
 
 
TBBMC 
TBBMC net gain 
TBBMD 
0.33 +/- 0.042 
 
 
 
Unstandardized Beta+/-SE (adjusted for 
sex, current height and weight, physical 
activity level, and other dietary nutrients) 
Females only with adequate calcium at 
pert-adolescence/early adulthood 
0.21+/- 0.095 
0.21+/-0.080 
0.32+/-0.32 
<0.001 
 
 
 
 
 
 
 
 
 
<0.05 
<0.05 
<0.05 
Wang et al, 1997, 
USA 
0.97  DXA  Older post F 125 LSBMD 
FNBMD 
0.04 
-0.01 
Spearmans correlations 
 
Ns 
Ns 
Wang et al. 1999, 
USA 
1.05 g/Kg/d QUS 18-18 year old 
women 
63 Bone indices at18-19 
years 
 
BUA 
BV 
SOS 
 
BUA 
BV 
SOS 
Protein intake when aged 9-11 years:  
 
Spearmans Rho 
0.16 
0.27 
0.25 
Pearson¶s: 
0.11 
0.21 
0.17 
 
Coefficients  not  shown for multiple 
regression as ns for protein (adjusted for 
calcium, magnesium, vitamin C, race, 
height and weight)- no effect size 
 
 
 
ns 
<0.05 
Ns 
 
Ns 
Ns 
Ns 
 
 
Weikert et al, 
2005, Germany 
67.9g/d QUS/BUA F 35-67y 8178 Os calcis 
TP 
AP 
VP 
AP:VP ratio 
TP 
 
 
Beta (Standardized) coefficient 
-0.03 (0.013) 
-0.03 (0.012) (controlling for VP) 
0.11  (0.042) (controlling for AP) 
-1.12 (0.31) (controlling for TP) 
0.014 (0.017) (controlling for AP:VP ratio) 
 
Pearson¶s Correlations: r 
 
0.017 
0.010 
0.007 
<0.001 
0.41 
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VP 
AP 
TP 
0.03 
0.02 
0.03 
0.009 
0.015 
0.002 
Whiting et al, 
2002, Canada 
1.15  DXA  M 
39-42y 
57  
TBBMD 
LSBMD 
THBMD 
 
 
 
 
TBBMD 
3HDUVRQ¶Vcorrelations: 
0.383(adj)    
0.419 (adj) 
0.322 (adj)* chosen for pooling men as 
closest to Jaime 
-controlling for anthropometry and energy 
intake 
 
Linear regression: (non-standardized B) 
0.00193 (0.00065) 
Adjusted for lean body mass, height, fat 
mass, energy intake 
 
 
<0.01 
<0.01 
<0.05 
 
 
 
 
<0.01 
Yazdanpanah et 
al, 2007, The 
Netherlands 
81.3g/d , 1.1g/Kg/d DXA Men and 
Women aged 
55 years and 
over 
5304  
 
 
FNBMD 
LSBMD 
Standardized Beta coefficient (adjusted for 
age, BMI, other dietary nutrients, sex) 
Protein intake: 
-0.03 
-0.03 
 
 
 
 
0.29 
0.27 
Zhang et al. 2010, 
China 
1.7 g/Kg/d DXA Girls (Mean 
age 10 years) 
757  
 
 
 
 
DRBMC 
DRBMD 
DRBA 
 
PRBMC 
PRBMD 
PRBA 
 
TBBMC 
TBBMD 
TBBA 
 
Beta( adjusted for baseline bone mass, 
tanner stage, age, physical activity).  Beta 
represents % change with doubling of 
protein intake: All participants: 
 
-4.82 
-3.18 
~ 
 
-10.2 
~ 
-9.11 
 
-1.92 
~ 
~ 
~=not entered into stepwise regression 
 
 
 
 
 
 
<0.01 
<0.01 
- 
 
<0.01 
- 
<0.01 
 
0.02 
- 
- 
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* simple r coefficients unless otherwise stated; for r2 the brackets indicate if corresponding regression coefficient + or - ** total protein in g/Kg/d unless otherwise stated. 
ALP= Alkaline Phosphatase; AP=animal protein; BMC=Bone Mineral Content; BMD=Bone Mineral Density; BUA-Broadband Ultrasound Attenuation; BV=Bone Volume; 
Calc=Calcaneus; Cr=Creatinine; Deoxypyd=Deoxypyridinoline; DRBA=Distal Radial Bone Area;  DRBD=Distal Radial Bone Density; DTB=Distal Tibial; DXA=Dual X-
ray Absorptiometry; FN=Femoral Neck; FNBA=Femoral Neck Bone Area; FNBMD=Femoral Neck Bone Mineral Density; FNvBMD=Femoral Neck volumetric Bone 
Mineral Density; FSBMD=Femoral Shaft Bone Mineral Density; HBMD=Humerus Bone Mineral Density; HPO=Hydroxyproline; HumBMC=Humerus Bone Mineral 
Content ;IntertrochBMD=Intertrochanter Bone Mineral Density; LSBMC=Lumbar Spine Bone Mineral Content; LSBMD=Lumbar Spine Bone Mineral Density; MRBMC 
Midradial Bone Mineral Content; MRBMD Midradial Bone Mineral Density; OC=Osteocalcin; P1NP= Procollagen type 1 N-terminal propeptide; PC=Periosteal 
Circumference; pQCT=Peripheral Quantitative Computed Tomography; PRBMC=Proximal Radial Bone Mineral Content; PYD=Pyridinoline; QUS=Quantitative Ultrasound; 
R=Radial RBMC=Radial Bone Mineral Content; sBAP=serum Bone Alkaline Phosphatase; sCTX serum C-telopeptide of collagen; sOC serum Osteocalcin; SP=Soy Protein; 
SSI=Stength Strain Index; Stand.=Standardised; TBBA=Total Body Bone Area; TBBMD Total Body Bone Mineral Density; TP=Total Protein; TrochBMD=Trochanter Bone 
Mineral Density; UBMC=Ulna Bone Mineral Content; uNTX=Urinary n-telopeptide of collagen; vBMD=volumetric Bone Mineral Density; VP=Vegetable Protein; 
WBBMC=Whole Body Bone Mineral Content; WBBMD=Whole Body Bone Mineral Density 
Table S2 Pooled r values for protein intake and bone health for gender and age subgroups (non-adjusted data)  
 
Parameter Model r R2 Lower 
limit 
Upper 
limit 
p I2 Total n Included Studies 
MEN BMD Fixed 0.1201 0.01 0.0291 0.2091 0.010 44% 470 Coin, Jaime(Black), Jaime(White), Whiting 
 Random 0.1549 0.02 0.0184 0.2858 0.026    
MEN BMC Fixed 0.2881 0.08 0.1346 0.4281 0.0003 0% 154 Orwoll(group 1), Orwoll (group 2) 
 Random 0.2881 0.08 0.1346 0.4281 0.0003    
POST F BMD Fixed 0.1148 0.01 0.0791 0.1502 <0.001 1% 2987 Alissa 2014, Cooper, Chiu, Devine, Gunn, Horiuchi, 
Lau, Rapuri, Thorpe 2008, Wang 1997 
 
Random 0.1147 0.01 0.0787 0.1503 <0.001    
POST F BMC Fixed 0.181 0.03 0.0618 0.2941 0.003 0% 267 Freudenheim, Lacey, Rubinacci (Early Post), 
Rubinnacci (Late Post) 
 Random 0.181 0.03 0.0618 0.2941 0.003    
PRE F BMD Fixed 0.0748 0.01 0.0384 0.1111 <0.001 74% 2896 Chan 2009, Chiu, Cooper, Gregg, Henderson, Hirota, 
Lau, New, Orozco, Quintas 
 
Random 0.1158 0.01 0.0376 0.1925 0.004    
PRE F BMC Fixed 0.2834 0.08 0.1986 0.3640 <0.001 47% 485 Freudenheim, Lacey, Teegarden, Quintas 
 
Random 0.2748 0.08 0.1442 0.3959 <0.001    
OLDER ADULT 
(OVER 60 YEARS) 
M/F BMD 
Fixed 0.1131 0.01 0.0736 0.1522 <0.001 0% 2448 Chiu, Coin, Devine, Gunn, Lau, Rapuri, Thorpe2008, 
Wang1997 
 
Random 0.1131 0.01 0.0736 0.1522     
CHILD M/F BMC* Fixed 0.3154 0.10 0.2251 0.4003 <0.001 0% 416 Bounds, Chevalley 2008, Ekbote, Hoppe 
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Random 0.3154 0.10 0.2251 0.4003 <0.001    
BMD=Bone Mineral Density BMC=Bone Mineral Content n=number of partipcnats in analysis *only radius BMC and total body BMC available for pooling.  Where studies have multiple 
outcomes eligible for inclusion, choice of measures for pooling was as follows: Hip indices (first choice), Spine indices (2nd choice), Radial indices (3rd choice).  
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Table S3: Pooled r values for protein intake and bone health by outcome (non-adjusted data) 
Parameter Model r R2 Lower 
limit 
Upper 
limit 
p I2 Total 
n 
Included Studies 
ADULTS          
TBBMC Fixed 0.12 0.01 0.0662 0.1683 <0.001 73% 580 Ho, Loenekke, Meng, Teegarden, 
 
Random 0.14 0.02 0.0133 0.2622 0.0304   
DEPYD Fixed -0.23 0.05 -0.3859 -0.052 0.01 0% 128 Horiuchi, Nakamura 
 
Random -0.23 0.05 -0.3859 -0.052 0.01   
FNBMD Fixed 0.07 0.00 0.0374 0.0942 <0.001 26% 4786 Alissa 2014, Chan 2009, Chiu, Coin, Cooper (post), Cooper (pre), 
Gunn, Henderson, Ho, Jaime(Black), Jaime (White), Kumar, Lau, 
Michaelsson, New, Orozco, Rapuri, Teegarden, Wang 
 
Random 0.07 0.00 0.0391 0.1090 <0.001   
FEMORAL 
SHAFT BMD 
Fixed 0.06 0.00 -0.0394 0.1563 0.240 0% 405 Cooper(post), Cooper(pre), Henderson 
 
Random 0.06 0.00 -0.0394 0.1563 0.240   
TROCH/INTTRO
CH BMD 
Fixed 0.09 0.008 0.0528 0.1330 <0.001 68% 2375 Coin, Cooper (post), Cooper (pre), Henderson, Lau, New, Orozco, 
Rapuri, Teegarden 
 
Random 0.12 0.014 0.0401 0.2027 0.004   
TOTAL HIP BMD Fixed 0.09 0.008 0.0389 0.1491 0.001 86% 1259 Alissa 2014, Chan 2009, Coin, Quintas, Thorpe M, Whiting 
 
Random 0.14 0.02 -0.0118 0.2919 0.07   
WARDS BMD Fixed 0.02 0.0004 -0.0325 0.0654 0.51 0% 1616 Kumar, Lau, New, Orozco, Teegarden 
 
Random 0.02 0.0004 -0.0325 0.0654 0.51   
HUMERUS BMC Fixed 0.16 0.03 -0.0613 0.3648 0.16 0% 84 Freudeneheim (Post), Freudenheim (Pre) 
 
Random 0.16 0.03 -0.0613 0.3648 0.16   
HYDROXYPROL
INE 
Fixed -0.07 0.00 -0.1838 0.0466 0.24 68% 290 Cooper (post), Cooper (pre) 
 
Random -0.11 0.01 -0.3363 0.1240 0.35   
LSBMD Fixed 0.07 0.005 0.0410 0.1012 0.0001 58% 4257 Chiu, Cooper (post), Cooper (pre), Henderson, Ho, Horiuchi, Kumar, 
Lau, Michaelsson, Quintas, Rapuri, Thorpe M, Teegarden, Wang, 
Whiting 
 
Random 0.09 0.008 0.0373 0.1385 0.0007   
LSBMC Fixed 0.31 0.10 0.2329 0.3876 <0.001 41% 533 Orwoll (group 1), Orwoll (group 2), Teegarden, Quintas 
 
Random 0.31 0.10 0.2057 0.4146 <0.001   
RADBMD Fixed 0.07 <0.01 0.0180 0.1267 0.009 53% 795 Cooper (post), Cooper (pre), Hirota, Quintas, Rapuri, Teegarden 
 
Random 0.07 <0.01 -0.0101 0.1574 0.084   
OSTEOCALCIN Fixed 0.00 0.00 -0.0817 0.0809 0.99 40% 593 Cooper (post), Cooper (pre), Horiuchi, Nakamura, Michaelsson 
 
Random -0.01 0.00 -0.1175 0.1039 0.90   
RADBMC Fixed 0.16 0.026 0.0987 0.2268 <0.001 0% 915 Freudeneheim (Post), Freudenheim (Pre), Lacey (Pre), Lacey (Post), 
Orwoll (group 1), Orwoll (group 2), Quintas, Rubinacci (early post), 
Rubinacci (late post), Teegarden 
 
Random 0.16 0.026 0.0987 0.2268 <0.001   
TOTAL BODY 
BMD 
Fixed 0.17 0.03 0.114 0.2334 <0.001 59% 1028 Knurick, Loenekke, Michaelsson, Rapuru, Teegarden, Whiting 
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Random 0.22 0.05 0.0114 0.3263 <0.001   
ULNABMC Fixed -0.02 0.00 -0.2395 0.197 0.84 0% 84 Freudeneheim (Post), Freudenheim (Pre) 
 
Random -0.02 0.00 -0.2395 0.197 0.84   
TOTALHIP BMC Fixed 0.16 0.026 0.0766 0.2330 0.001 94% 602 Ho, Quintas 
 
Random 0.24 0.06 -0.1358 0.5494 0.211   
 
Random 0.13 0.02 0.0771 0.1913 <0.001    
CHILDREN          
ALL BMC* Fixed 0.32 0.10 0.2251 0.4003 <0.001 0% 416 Bounds, Chevalley 2008,  Ekbote, Hoppe 
 
Random 0.32 0.10 0.2251 0.4003 <0.001   
TBBMC Fixed 0.37 0.14  0.2386 0.4927 <0.001 0% 184 Bounds,  Ekbote, Hoppe 
 
Random 0.37 0.14 0.2386 0.4927 <0.001   
TBBA Fixed 0.48 0.23 0.3591 0.5892 <0.001 79% 176 Ekbote, Hoppe 
 
Random 0.46 0.21 0.1641 0.6821 0.003   
TBBMD Fixed -0.02 0.0004 -0.1322 0.0901 0.71 87% 314 Bounds, Jones 
 
Random 0.11 0.01 -0.3055 0.4853 0.62 
  
$OOSRROHGHIIHFWVFDOFXODWHGLQ5XVLQJµPHWD¶DQGµPHWDFRU¶SDFNDJHVZKLFKXVHWKHLQYHUVHYDULDQFHPHWKRG'HU6LPRQLDQDQd Laird (random effects models) DQG)LVKHU¶V
Z Transformation. BMD=Bone Mineral Density DEPYD=Deoxypyridinoline FNBMD= Femoral Neck Bone Mineral Density INTTROCH=Intertrochanter LSBMC=Lumbar 
Spine Bone Mineral Content LSBMD=Lumbar Spine Bone Mineral Density RADBMC= Radial Bone Mineral Content RADBMD= Radial Bone Mineral Density 
TBBA=Total Body Bone Area, TBBMC=Total Body Bone Mineral Content, TBBMD=Total Body Bone Mineral Density TROCH=Trochanter ULNABMC=Ulna Bone 
Mineral Content 
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Table S4 Associations between protein dose, calcium dose and calcium:protein ratio and FNBMD and LSBMD (non-adjusted for confounders) 
 
Linear Model 
X r for 
FNBMD 
   r for 
LSBMD 
   Actual 
FNBMD 
   Actual 
LSBMD 
   
Model Estimate* SE Model P N 
studies 
Estimate
* 
SE Model P N 
studies 
Estimate
* 
SE Model P N 
studies 
Estimate
* 
SE Model P N 
studies 
Protein 
(g/kg/d) 
-0.05 0.16 0.76 16 0.25 0.18 0.19 14 0.39 0.15 0.02 19 0.33 0.13 0.02 16 
Calciu
m 
(mg/kg/
d) 
-0.01 0.008 0.17 16 0.007 0.01 0.57 17 0.02 0.010 0.06 19 0.02 0.010 0.06 17 
Ca:Prot 
ratio 
(mg/g/d
) 
-0.01 0.01 0.20 18 -0.008 0.02 0.63 17 0.0005 0.013 0.97 19 0.005 0.01 0.74 17 
*Intercept not shown for clarity. Equation: y=x+c (where c=intercept, y=dependent variable). Note: No results were statistically significant after Bonferroni correction (36 tests, 
0.05/36=0.001) Note: some studies had Ca:Prot ratio but not protein or calcium. This is because for some studies the body weight was not given so protein in g/Kg/d was not 
calculated. However, if studies gave Ca mg/d and Protein g/d the Ca:Prot ratio could still be calculated for these studies. Ca=Calcium FNBMD=Femoral Neck Bone Mineral Density 
LSBMD= Lumbar Spine Bone Mineral Density N Studies =Number of studies Prot=Protein SDE=Standard Error 
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Quadratic model 
X2 r for 
FNBMD 
   r for 
LSBMD 
   Actual 
FNBMD 
   Actual 
LSBMD 
   
Model Estimate* SE Model P N 
studies 
Estimate
* 
SE Model P N 
studies 
Estimate
* 
SE Model P N 
studies 
Estimate
* 
SE Model P N 
studies 
Protein2 
(g/kg/d) 
-1.28 1.16 0.53 16 1.26 0.87 0.17 14 0.33 0.77 0.06 19 0.28 0.70 0.08 16 
Calciu
m2 
(mg/kg/
d) 
-0.0007 0.003 0.40 16 0.002 0.004 0.75 17 0.0003 0.003 0.18 19 -0.0004 0.003 0.19 17 
Ca:Prot 
ratio2 
(mg/g/d
) 
-0.002 0.003 0.38 18 -0.003 0.004 0.75 17 -0.002 0.004 0.89 19 1.3 x  
10-5 
4.4 x  
10-3 
0.95 17 
*Other model estimates not shown for clarity. Ca=Calcium, Prot=Protein. Equation: y=x+x2+ c (where c=intercept, y=dependent variable). Note: No results were statistically 
significant after Bonferroni correction (36 tests, 0.05/36=0.001). Note: some studies had Ca:Prot ratio but not protein. This is because for some studies the body weight was not given 
so protein in g/Kg/d was not calculated. However, if studies gave Ca mg/d and Protein g/d the Ca:Prot ratio could still be calculated for these studies. Ca=Calcium FNBMD=Femoral 
Neck Bone Mineral Density LSBMD= Lumbar Spine Bone Mineral Density N Studies =Number of studies Prot=Protein SDE=Standard Error 
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Cubic model 
X3 r for 
FNBMD 
   r for 
LSBMD 
   Actual 
FNBMD 
   Actual 
LSBMD 
   
Model Estimate* SE Model P N 
studies 
Estimate
* 
SE Model P N 
studies 
Estimate
* 
SE Model P N 
studies 
Estimate
* 
SE Model P N 
studies 
Protein3 
(g/kg/d) 
0.06 0.40 0.74 16 -0.10 0.46 0.33 14 -0.90 0.36 0.01 19 -0.84 0.29 0.009 16 
Calciu
m3 
(mg/kg/
d) 
-0.0006 0.001 0.56 16 -0.0008 0.002 0.86 17 4.9 x 10-
5 
1.4 x 
10 -3 
0.35 19 -0.0003 0.001 0.35 17 
Ca:Prot 
ratio3 
(mg/g/d
) 
-0.001 0.001 0.51 18 -0.0002 0.002 0.91 17 -0.001 0.002 0.84 19 -0.003 0.002 0.58 17 
*Other model estimates not shown for clarity. Ca=Calcium, Prot=Protein. Equation: y=x+x2+x3+ c (where c=intercept, y=dependent variable)  Note: No results were statistically 
significant after Bonferroni correction (36 tests, 0.05/36=0.001). Note: some studies had Ca:Prot ratio but not protein. This is because for some studies the body weight was not given 
so protein in g/Kg/d was not calculated. However, if studies gave Ca mg/d and Protein g/d the Ca:Prot ratio could still be calculated for these studies. Ca=Calcium FNBMD=Femoral 
Neck Bone Mineral Density LSBMD= Lumbar Spine Bone Mineral Density N Studies =Number of studies Prot=Protein SDE=Standard Error 
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Table S5: Characteristics and outcomes of the 29 studies reporting fracture or osteoporosis diagnosis data (6 of which also in Table 1) 
a) 14 Cohort studies 
Study  Mean 
Protein
*  
Populatio
n  
Lengt
h 
Total n Fracture
/ BMD 
site 
Protein 
type 
55 95% CI P value Confounder Adjustments 
Beasley et al. 
2014, USA 
<13.3% 
to 

of 
energy  
intake 
from 
protein 
Women 
aged 50-
79 y at 
baseline 
6y 144,58
0 
 
Any 
Hip 
Spine 
Forearm 
 
TP 
TP 
TP 
TP 
HR: 
0.99 
0.91 
1.05 
0.93 
 
(0.97, 
1.02) 
(0.84, 
1.00) 
(0.98, 
1.13) 
(0.88, 
0.98) 
 
- 
- 
- 
- 
Age, BMI, race-ethnicity, calibrated energy intake, general 
health, physical activity, history of fracture at age 55 y, 
history of parental 
fracture, current smoking, corticosteroid use, glucocorticoid 
use, treated diabetes, 
rheumatoid arthritis, and hormone use 
Dargent-
Molina et al, 
2008, France 
E3N study 
TP: 
46(7.5)g
/d 
AP:29 
(8.8) g/d 
VP: 
12(3.0)g
/d 
Postmenop
ausal 
women 
8.37 
(1.73) 
y 
36217 
(2408 
with 
inciden
t 
fractur
e, 
33809 
fractur
e free) 
Any low  
impact 
fracture 
Energy 
adjuste
d 
TP 
AP 
VP 
 
 
 
1.06 
1.10 
0.95 
 
 
0.94-1.19 
0.98-1.24 
0.85-1.06 
 
 
- 
- 
- 
(Also has calcium intake stratification data) 
 
Adjusted for BMI, physical activity, parity, maternal history 
of hip fracture, HT use, smoking status, 
and alcohol intake 
Feskanich et 
al, 1996, USA 
79.6g/d 
median 
Caucasian 
F, 35-59y  
12y 85,900  
FF 
 
 
HF 
 
AP 
TP 
VP 
AP 
TP 
VP 
 
1.25 
1.22 
0.9 
0.98 
0.96 
1.11 
 
1.07-1.46 
1.04-1.43 
0.77-1.06 
0.65-1.47 
0.64-1.45 
0.75-1.66 
 
0.004 
0.01 
0.17 
0.7 
0.7 
0.58 
Adjusted for questionnaire time period; age (5-year intervals), 
BMI and hours of 
vigorous activity per week (qulntjles); menopause) status and 
use of postmenopausal hormones (premenopausal, 
postmenopausal-never 
user, postmenopausal-past user, postmenopausal-current 
user); cigarette smoking (never, past, current); use of thyroid 
hormone medication 
and thiazlde diuretics (yes or no); and alcohol and caffeine 
Intakes (quintiles). 
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Study  Mean 
Protein
*  
Populatio
n  
Lengt
h 
Total n Fracture
/ BMD 
site 
Protein 
type 
55 95% CI P value Confounder Adjustments 
Gunn et al, 
2014, New  
Zealand 
79g/d Bone 
markers, 
DXA 
POM 
wome
n, 60 
years 
of age 
142 Osteopo
rosis 
diagnosi
s) 
 
TP 
Mean(
SD) 
Protei
n 
intake 
by 
catego
ry: 
BMD:  
Normal 
79(21) 
 
Mild 
Osteope
nia 
83(18) 
Significa
nt 
osteopen
ia 77(22) 
Osteopor
osis 
76(21)  
n 
 
51 
 
 
 
 
21 
 
 
 
 
53 
 
 
17 
 
NS 
Non confounder adjusted 
Key et al, 
2007, UK 
Women: 
73.1 
(21.6) 
g/d 
77.8(22.
6)g/d 
26 749 
women 
and 7947 
men aged 
20±89 
years. 
5.2y 26 749 
women
, 7947 
men, 
aged 
20±89 
years 
All sites, 
incident 
fractures 
(includin
g high 
trauma 
fractures, 
but still 
72% 
from a 
fall) 
 
 
 
TP: 
Women 
n=362 
fracture
s 
Men 
n=76 
fracture
s 
Incident 
Rate 
Ratio: 
 
0.97 
 
1.29 
 
 
 
 
0.74-1.27 
 
0.72-2.31 
 
 
 
 
0.55 
 
0.68 
Confounder adjusted: Method of recruitment and adjusted for 
age, smoking, intakes of energy and each other nutrient, 
alcohol consumption, 
body mass index, walking, cycling, vigorous exercise, other 
exercise, physical activity at work, marital status and, for 
women, parity and use of hormone replacement therapy  
Langsetmo et 
al, 2015, 
Canada 
TP: 
0.79(0.6
0-1.03) 
AP 
(Non-
dairy): 
17.6(12.
8-23)g/d 
Men and 
Women, 
aged 25-
49 and 
\HDUV 
5y 6510 Fragility 
fracture:  
n=4543 
 
 
 
 
 
 
TP: 
Men 
Women
: 
 
 
 
HR= 
 
0.66 
0.85 
 
 
 
 
 
 
0.35-1.24 
0.67-1.09 
 
 
 
 
 
 
- 
 
 
 
 
 
Confounder adjusted: 
Age, height, TEI, center (women only), education, smoking, 
alcohol intake, physical activity, sedentary hours, calcium and 
vitamin D supplement use, hormone therapy (women only), 
bisphosphonate use (women only), and diagnosis of 
osteoporosis (women only); 
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Study  Mean 
Protein
*  
Populatio
n  
Lengt
h 
Total n Fracture
/ BMD 
site 
Protein 
type 
55 95% CI P value Confounder Adjustments 
VP: 
24.3(18.
8-
31.0)g/d 
Main 
fracture: 
n=4570 
 
TP: 
Men 
Women
: 
 
0.55 
0.90 
 
0.28-1.09 
0.69-1.19 
 
- 
Meyer et al, 
1997, 
Norway 
0.8 M/F 
(mean age 
47.1y) 
11.4y   19752 
F  
20035 
M 
HF- F 
HF-M 
 
AP 
AP 
 
0.96 
1.3 
Q4= 
highest: 
0.62-1.49 
0.63-2.68 
 
Q1=refer
ence, 
RR=1, 
lowest 
 
0.37 
0.48 
Adjusted for age at screening, body height, body mass index, 
serf-reported physical activity at work and during leisure 
time, diabetes mellltus, disability pension, marital status, and 
smoking 
Misra et al, 
2011, USA 
64g/d 
(energy 
adjusted
) 
Men and 
women 
mean 
age=75 
years 
11.6y 946 
(n=100 
had hip 
fractur
e) 
HF TP: 
M/F 
(n=100
) 
F 
(n=80) 
HR= 
 
0.63 
 
0.82 
 
 
0.37-1.09 
 
0.44-1.51 
 
 
- 
 
- 
Confounder adjusted: age, sex, weight, height and total 
energy intake 
Munger et al, 
1999, USA 
1.2 Postmenop
ausal F 
(55-69y)  
1-3y 32 050 HF  
AP 
TP 
VP 
RR= 
0.31 
0.44 
1.92 
 
0.10-0.93 
0.16-1.22 
0.72-5.11 
 
0.037 
0.049 
0.11 
Age, body mass index, number of pregnancies, smoking, 
alcohol use, estrogen use, and physical 
activity. 
Mussolino et 
al, 1998, USA 
<56g/d -
>98g/d 
Caucasian 
M (45-
74y) 
22y 2879 HF  
TP 
RR: 
0.55 
 
0.20-1.55 
- BMI, previous fracture, smoker, physical activity, alcohol, 
chronic health condition, calcium intake, weight loss. 
Sahni et al, 
2010, USA 
 
Framingham 
Offspring 
Study 
Men 
TP: 
79.0(27)
g/d 
AP: 
54.3(22) 
VP: 
24.6(9) 
 
Men and 
women 
aged 
mean= 55 
(9.9)years 
7 to 14 
years 
3656 HF Low  
calcium 
intake 
(<800 
mg/d) 
n=2124
: 
 
HR for 
highest 
tertile of 
protein 
intake: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted for sex and menopause status (group 1: men; group 
2: premenopausal women; group 3: postmenopausal women), 
age 
(years), weight at baseline (kg), height at baseline (m), 
physical activity index, intake of energy (MJ/day) and total 
vitamin D (IU/day), and smoking status (current versus 
former/never) and calcium intake 
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Study  Mean 
Protein
*  
Populatio
n  
Lengt
h 
Total n Fracture
/ BMD 
site 
Protein 
type 
55 95% CI P value Confounder Adjustments 
Women: 
TP:75.7(
27) 
AP: 
52.5(22) 
VP: 
23.1(9) 
Energy 
adjuste
d TP: 
g/d 
AP:g/d 
VP:g/d 
AP:VP 
ratio 
 
High 
calcium 
intake 

mg/d) 
n=1532 
 
Energy 
adjuste
d TP: 
g/d 
AP:g/d 
VP:g/d 
AP:VP 
ratio 
 
2.20 
3.17 
0.60 
1.81 
 
 
 
 
 
 
 
 
 
 
 
0.54 
0.32 
0.23 
2.02 
0.88-5.54 
1.30-7.78 
0.20-1.85 
0.68-4.86 
 
 
 
 
 
 
 
 
 
 
 
0.12-1.30 
0.05-2.08 
0.05-1.03 
0.37-
11.05 
0.09 
0.01 
0.34 
0.29 
 
 
 
 
 
 
 
 
 
 
 
0.38 
0.33 
0.06 
0.32 
Sellmeyer et 
al, 2001, USA 
49.8g/d Caucasian 
F  aged 
over 65y 
7.0y 
+/- 
1.5y 
1035  Hip 
Fracture 
 
VP 
Ratio 
AP:VP 
AP 
 
0.3 
3.7 
 
2.7 
 
- 
- 
 
- 
 
0.03 
0.04 
 
0.04 
Age and body weight 
Zhong et al, 
2009 USA 
Mean(S
E)=61+/
-0.8 g/d 
Postmenop
ausal 
women at 
least 50 y 
of age 
<7y 2006 All 
fragility 
fractures 
(hip, 
wrist, 
spine) 
TP OR data 
 
 
Data in 
Figure 
Only 
 
  
- 
 
 
 
 
Age, race, body mass index (underweight/normal, overweight, 
obese), physical activity level, smoking status, alcohol use 
(heavy, moderate/none), hormone use, general health status, 
osteoporosis, arthritis, vision impairment, and stroke. 
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Study  Mean 
Protein
*  
Populatio
n  
Lengt
h 
Total n Fracture
/ BMD 
site 
Protein 
type 
55 95% CI P value Confounder Adjustments 
Zhang 2005 SP: 
9.6g/d 
Non 
Soy: 
134g/d 
Women 
aged 40-
70 years 
old 
4.5 y 24403 All 
fractures 
SP <4.98 
g/d 
(Referen
ce) 
 

g/d 
0.63 
 
 
 
 
 
 
 
0.53-0.76 
 
 
 
 
 
 
 
<0.001 
Age, body mass index, hours of exercise per week, 
cigarette smoking, alcohol consumption, history of 
diabetes mellitus, level of education, family income, 
season of recruitment, and intakes of total calories, 
calcium, non-soy protein, fruits, and vegetables 
AP, Animal Protein; BMD, Bone Mineral Density; DXA, Dual X-ray Absorptiometry; HF, Hip Fracture; HR, Hazard Ratio; POM, Postmenopausal; RR, 
Relative Risk; SP, Soy protein; TEI, Total Energy Intake; TP, Total Protein; VP, Vegetable Protein 
 
4b.2 Cross cultural studies 
Study Mean 
Protein 
** 
Method  Population n Outcome Coefficient* p Confounders 
Abelow et al, 
al1992, USA cross 
cultural 
10.4g/d-
77.8g/d 
AP 
Fracture F over 50y 34 studies 
16 countries 
Hip fracture 
and animal 
protein 
 
r2=0.66(+) (by 
study) 
r2=0.67 (+) (by 
country) 
 
<0.001 
 
<0.001        
Age adjusted 
Frassetto et al, 
2000, USA Cross 
Cultural 
48 to 
110.9 g/d 
Fracture F aged 
over 50y 
33 countries Hip fracture 
TP 
AP 
VP 
 
0.67;  
0.82;  
-0.370; 
 
p<0.001 
p<0.001 
p<0.04 
Age. Also, for AP, TP and VP 
AP, Animal Protein; TP, Total Protein; VP, Vegetable Protein 
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4c 13 Case control studies   
Study Protein 
intake* 
Population n Site Group/outcome OR* p Confounders 
Alissa et al, 
2011, Saudi 
Arabia  
Non-
Prospective 
77g/d DXA Postmenopausal 
women, aged 
50-60 years 
122  
 
Normal BMD 
Osteopenic 
Dietary protein intake 
g/d 
77.5 
76.6 
 
 
ns 
Non adjusted for confounders 
 
Chevalley 
et al. 2011, 
Switzerlan
d 
 
 
Age 7.4 (0.4): 
1.78 (0.46) 
Age 15.2(0.5): 
1.08 (0.41) 
 
 
DXA Caucasian 
boys- measured 
during pre-
puberty and 
adolescence 
176  
Age 7: 
Without Fracture: 
n=89 
With Fracture: 
n=87 
 
Age 15: 
Without Fracture 
:n=89 
With Fracture: 
n=87 
Dietary Intake, (g/d) 
 
48.5 (13.3) 
45.2(11.1) 
 
 
65.4 (24.1) 
61.2 (23.1) 
 
 
 
 
0.08 
 
 
 
0.24 
 Non adjusted for confounders 
Chiu et al, 
1997, 
Taiwan   
 
Non-
Prospectiv
e 
1.09  DPA 
(BMD) 
Older POM F 258 Osteopenia of: 
 
Lumbar Spine 
Femoral Neck 
Energy intake from 
protein (%) 
0.51 (0.30-0.89) 
0.71 (0.33-1.54) 
- 
 
Significant 
NS 
Adjusted for age, BMI, physical 
activity, calcium intake, non-protein 
energy intake, long term 
vegan/vegetarianism 
Coin et al, 
Italy, 2008 
 
Non-
Prospective 
 
75.8+/-22.1 g/d 
Weight=74.2+/-
13.4 
 
So  1.02 g/Kg/d 
DXA Males, mean 
age 73.9+/-5.6 
years 
136 Only data for 
men included 
protein in model: 
MEN 
Protein<65.7g/d 
Protein>=65.7g/d 
OR (95% CI) of low 
total hip 
BMD<=0.83h/cm2) 
 
3.69 (1.40-9.70) 
1.00          
 
 
 
0.008 
- 
Adjusted for BMI 
Farrin et 
al. 2008, 
Iran 
 
81.4g/d DXA Postmenopausal 
Women 
58 LSBMD based 
diagnosis: 
Normal 
Osteopenic 
Mean (SD) Protein 
intake:g/d 
68.7 +/- 5.0 
95.5+/- 67.6 
One way 
ANOVA 
p<0.05 
 
Unadjusted 
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Non-
prospective 
 
 
Osteoporotic 
 
67.6+/-5.3 
 
Post hoc 
tests: 
Normal-
Osteopenia: 
P=0.009 
Normal-
Osteoporoti
c P=0.75 
 
Kim et al, 
2008, 
Korea 
 
Non-
prospective 
TP= 60g/d 
AP= 19g/d 
VP= 40g/d 
DXA Postmenopausal 
women, 134 
osteoporotic  
cases and 137 
non-
osteoporotic 
controls 
271  
 
 
 
Osteoporotic 
(n=134) 
Non-
Osteoporotic 
(n=137) 
 
 
Osteoporotic 
(n=134) 
Non-
Osteoporotic 
(n=137) 
 
 
 
Osteoporotic 
(n=134) 
Non-
Osteoporotic 
(n=137) 
OR for Osteoporosis 
by protein intake: 
 
TP: g/d 
Lowest 1.0(reference) 
Middle 0.91 (0.68-
1.21) 
Highest 1.47 (1.03-
2.05) 
 
AP: g/d 
Lowest=1.0 (reference) 
Middle= 1.21(0.58-
2.52) 
Highest= 1.62(1.03-
3.92) 
 
VP: g/d 
Lowest=1.0(reference) 
Middle=0.62(0.31-
1.23) 
Highest=0.42(0.23-
0.83) 
 
 
 
 
 
 
P=0.004 
 
 
 
 
 
 
P=0.03 
 
 
 
 
 
 
 
P=0.011 
Adjusted for age, smoking, alcohol 
drinking, BMI, exercise, family history 
of osteoporosis, and energy intakes 
Martinez-
Ramirez  et 
al, 2012, 
Spain 
 
TP:105 (1.0) 
g/d 
AP:66-70 (1.3) 
g/d 
VP: 38 
(0.63)g/d 
Aged 65 
years or 
over, cases 
from 
hospital 
record and 
167 cases and 
167 controls 
All low  
energy 
fractures 
(e.g. from 
a fall) 
 
TP 
AP 
VP 
AP:VP ratio 
OR: 
1.10 (0.18, 6.80) 
0.38 (0.10-1.41) 
0.52(0.16-1.65) 
0.75(0.14-3.99) 
 
 
0.291 
0.115 
0.460 
0.121 
Adjusted for age, sex, energy intake, 
vegetable protein intake or animal 
protein 
intake (according to the analysis), serum 
vitamin C, calcium intake, underlying 
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Non-
Prospective 
AP:VP ratio: 2 
(0.1) g/d 
controls 
drawn from 
local 
community 
population, 
80% female 
FKURQLFGLVHDVHKRPHDFFHVV.DW]¶V
index, physical activity (METS), HDL 
cholesterol, 
and MUFA/PUFA intake. 
Nieves et al, 
1992, USA 
 
Non-
prospective 
<24g/d to 
>55g/d 
F 50 to 103y  329 (161 cases, 
168 controls) 
Hip (OR) Hip fracture 1.04 (0.43, 2.55) ns Hospital, age, BMI, oestrogen use, 
chronic disease status 
Park et al, 
2014, 
Korea 
 
Non-
prospective 
81.93+/-52.31 
g/d 
Z score from 
DXA 
Young Women 1157  
 
Z-6FRUH
(n=171) 
Z-score<0 
(n=986) 
Protein Intake g/d: 
 
85.96+/-55.81 
81.23+/-51.67 
 
 
 
 
0.276 
Non-adjusted 
Perez-
Durillo et 
al, 2011, 
Spain 
Non-
prospective 
Cases 60 
(19)g/d; 
controls 94 (19) 
g/d 
Women 
older than 
65 y, 
medical 
outpatients 
44 cases and 42 
controls 
HF % energy TP 
 
 
 
 
 
 
TP intake: (n=86) 
16.7 (4.7)% (cases 
(3.0)%) vs 18.3 
(control) 
 
OR of being a case: 
(continuous protein 
intake) 
0.96 
0.07 
 
 
 
 
 
 
0.92-1.00 
Non adjusted 
 
 
 
 
 
BMI, carbohydrate intake and calcium 
intake 
Preisinger 
et al, 1995, 
Austria 
 
Non-
prospective 
15 % total 
energy, 45-96 
g/d 
Osteoporosis 
diagnosis 
Post F 50-70 
years old 
23  
 
 
Group 1- 
Osteoporotic 
n=12 
 
Group 2 Non-
osteoporotic 
n=11 
 
Protein intake % 
mean+/-SEM 
 
TP 
15.5+/-0.9 
 
 
 
15.4+/-0.9 
 
AP (g/d) 
46.9+/-4.1 
 
 
 
 
NS 
Non adjusted 
70 
 
 
 
*in g/Kg/d unless otherwise stated, * *(Highest Quartile/Quintile oILQWDNHORZHVWTXDUWLOH 25 unless otherwise stated  
AP, Animal Protein; BMD, Bone Mineral Density; DPA, Dual Photon Absorptiometry; DXA, Dual X-ray Absorptiometry; LSBMD, Lumbar Spine Bone 
Mineral Density; OR, Odds Ratio; POM, Postmenopausal; TP, Total Protein; VP, Vegetable Protein 
 
 
  
Group 1- 
Osteoporotic 
n=12 
 
Group 2 Non-
osteoporotic  
n=11 
 
Group 1- 
Osteoporotic 
n=12 
 
Group 2 Non-
osteoporotic 
n=11 
 
 
42.8+/-3.3 
 
 
VP (g/d) 
25.0+/-4.1 
 
 
 
25.4+/-2.3 
 
 
Samieri et 
al, 2013, 
France 
 
Prospective  
70-76 g/d Men and 
women 65y 
and over 
1482 Incident 
fracture of  
hip, spine 
or wrist 
Cases  (n=155) 
Controls(n=1327) 
70.4 (26.3) g/d 
75.8 (26.8) g/d 
 
Baseline protein intake 
0.02  
 
 
Not adjusted for confounders 
Wengreen 
et al, 2004, 
USA 
 
Non-
prospective 
1.2g/Kg/d 50-89y  M/F 2501 (1157 
cases, 1334 
controls 
Hip (OR) 50-69y (TP) 
70-89y (TP) 
50-69y (AP) 
70-89y (AP) 
50-69y (VP) 
70-89y (VP) 
 
 
0.35 
1.28 
0.43 
1.54 
0.52 
0.79 
 
<0.001 
0.06 
0.21 
0.95 
0.19 
0.46 
BMI, smoking, alcohol, physical 
activity, oestrogen use, gender, total 
Calcium and Vitamin D intakes (diet 
and supplements), potassium intake, 
age. AP model also adjusted for VP 
intake, VP model also adjusted for AP 
intake. 
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TableS6: Characteristics and outcomes of the 30 intervention studies 
 
Study, 
Country, 
Design Baseline  
protein 
intake 
Supp. (g/d) 
vs control 
Subject 
Total n 
Outcomes 
Measured 
n (I) Mean, SD(I) n(p) Mean/SD(p) p 
Alekel et 
al, 2000, 
USA, 
24wks 
 
Parallel No 
information 
in paper 
Soy vs Whey 2002 
PERI F 
LSBMC 
LSBMD 
BAP 
24 
24 
24 
52.96+/-8.72 
0.933+/-0.12 
15.05+/-5.11 
21 
21 
21 
56.57+/-9.74 
0.989+/-0.132 
12.51+/-4.3 
Ns 
Ns 
- 
Aoe et al, 
2001, 
Japan 
 
Parallel No 
information 
in paper 
40mg/d 
MBP vs 
Placebo 
PRE F % change in 
Calcaneal 
BMD 
17 3.42+/-2.05 % 16 2.01+/-1.75 % 0.042 
Aoe et al 
2005,  
Japan, 6mo 
 
Parallel No 
information 
in paper 
MBP vs 
Inactive 
placebo 
27 PERI 
F 
NTX 
OC 
LSBMD 
14 
14 
14 
47.3+/-8.3 
5.73+/-0.59 
1.11+/-0.03 
13 
13 
13 
58.7+/-8.3 
5.82+/-0.59 
1.09+/-0.03 
Ns 
Ns 
<0.05 
Arjmandi 
et al, 2003, 
USA,  
3mo 
 
Parallel Mean (SE) 40g/d 
Soy protein 
vs MBP 
42 POM 
F 
BAP 
DPYD 
20 
20 
 
0.41+/-0.14 
7.19+/-3.31 
22 
22 
0.35+/-0.15 
6.79+/-3.24 
- 
- 
 
Cao et al, 
2011, USA 
 
Crossover- 
7 weeks in 
each arm 
Soy group ± 
60(6)g/d 
61g/d 
µORZHU
protein 
control- US 
daily 
recommenda
tion) vs. 
118g/d 
µKLJKHU
SURWHLQ¶
group) 
N=16  
40-75 
year old 
postmen
opausal 
women,  
NTX 
Log DPYD 
16 
16 
270 +/- 153 
3.7+/-0.61 
16 
16 
227+/-153 
3.5+/-0.61 
0.41 
0.20 
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Ceglia et 
al, 2009 
41 d  
Cross-over 
study 
MBP group 
(75(9) g/d  
0.5g/Kg/d 
(low) vs. 
1.5g/Kg/d 
(high) 
M/F 54-
82 years 
old  
N=10 
(placebo 
group 
used) 
OC (ng/mL) 
Urinary NTX/Cr 
(nmol/mmol) 
10 
10 
6.2+/-2.6 
41.0+/-15.2 
10 
10 
6.9+/-4.3 
40.4+/-19.1 
Ns 
ns 
Cuneo et 
al, 2010, 
Brazil 
Parallel No 
information 
in paper 
Hydrolysed 
collagen 
(10g/d 
protein) vs. 
maltodextrin 
placebo  
N=36 
collagen
, N=35 
placebo 
45-65 
year old 
post 
women 
BAP 
CTX 
OC 
36 
36 
36 
26.2(7.2) 
0.48(0.1) 
29.0(8.5) 
35 
35 
35 
 
32.0(10.6) 
0.57(0.2) 
31.8(10.5) 
- 
- 
- 
 
Dalais et 
al, 2003, 
AUS, 3mo 
 
Parallel Mean (SD): 
69.1 (22.1) 
g/d 
40g 
Soy protein 
vs casein 
placebo 
106 
POM F 
50-75 y 
PYD 
DPYD 
38 
38 
70+/-24.97 
14.48+/-8.15 
40 
40 
72.72+/-21.31 
14.19+/-6.58 
Ns 
ns 
Dawson-
Hughes et 
al 
2004,USA, 
63d 
 
Parallel Mean (SD)  High 
(0.75g/Kg/d) 
vs low  (0.04 
g/kg/d) 
protein  
32 
Elderly 
M/F 
 
NTX 
OC 
 
16 
16 
High protein 
102.3+/-34.5 
3.4+/-0.9 
 
16 
16 
Low protein 
170+/-118.4 
3.2+/-1.5 
 
0.038 
0.795 
Evans et 
al, 2007, 
USA 
9 mo 
Cross-over  67(18.8) g/d 
(placebo) 
Soy protein 
isolate (I) vs. 
Milk protein 
isolate (p),  
exercise 
counterbalan
ced across 
groups (1/2 
in each 
group 
exercise, ½  
in each 
group no 
exercise) 
Postmen
opausal 
women 
N=22, 
Mean 
age 63 
years 
Change in: 
TBBMD;  
LSBMD 
ProximalFemur
BMD 
FNBMD 
TrochBMD 
IntertrochBMD 
 
 
BAP 
CTX 
 
21 
21 
21 
 
21 
21 
21 
 
 
21 
21 
 
 
í0.009 ± 0.013  
í0.011 ± 0.028  
  0.002 ± 0.016 
 
  0.003 ± 0.022  
  0.004 ± 0.013 
  0.000 ± 0.025  
 
 
-2.1 ± 4.0  
í0.08 ± 0.09  
 
22 
22 
22 
 
22 
22 
22 
 
 
22 
22 
 
 
í0.011 ± 0.018 
í0.014 ± 0.022 
í0.003 ± 0.015 
 
í0.006 ± 0.025 
í0.002 ± 0.018 
í0.002 ± 0.023 
 
 
1.2 ± 4.7 
í0.02 ± 0.11 
 
 
0.72 
0.65 
0.29 
 
0.20 
0.23 
0.74 
 
 
0.02 
0.02 
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Hunt et al, 
2009, USA 
 
7wk each 
arm 
Cross-over 61.9(24) g/d 
(collagen) 
Low 
Calcium 
(LC)(670mg/
d) Low  
protein 
(10%of  total 
energy, 
0.8g/Kg/d) 
vs. High 
protein (20% 
of  total 
energy, 
1.6g/Kg/d) .  
 
HighCalcium 
(HC) 
(1500mg/d) 
Low  protein 
(10%of  total 
energy, 
0.9g/Kg/d) 
vs. High 
protein (20% 
of  total 
energy1.7g/
Kg/d) .  
 
 
N=13 in 
two LC 
arms, 
n=14 in 
two HC 
arms 
 
POM F 
Group 1 LC: 
LCLP (p) vs. 
LCHP (I) 
 
Log DPYD 
Log OC 
BAP 
TRAP 
 
Group 2 HC: 
HCLP (p) vs. 
HCHP(I) 
 
Log DPYD 
Log OC 
BAP 
TRAP 
 
 
 
 
 
 
 
 
 
 
13 
13 
13 
13 
 
 
 
 
 
 
14 
14 
14 
14 
 
 
 
 
 
 
2.3 (0.2) 
1.74(0.74) 
0.55(0.08) 
52.5(8.0) 
 
 
 
 
 
 
2.2(0.2) 
1.90(0.74) 
0.58(0.02) 
57.6(8.0) 
 
 
 
 
13 
13 
13 
13 
 
 
 
 
 
 
14 
14 
14 
14 
 
 
 
 
2.4 (0.2) 
1.94(0.74) 
0.52(0.08) 
55.1(8.0) 
 
 
 
 
 
 
2.3(0.2) 
1.73(0.74) 
0.53(0.02) 
55.7(8.0) 
 
 
 
- 
- 
- 
- 
 
 
 
 
 
 
- 
- 
- 
- 
Ince et al 
2004, 
USA, 
2wks  
 
Cross-over 109(7) g/d 
Soy group 
High 
(1.1g/Kg/d) 
vs low 
(0.8g/Kg/d) 
protein diet 
39 Pre 
F, 22-
39y 
 
NTX 
OC 
 
39 
39 
High protein 
442+/-124.9 
15.8+/-8.74 
 
39 
39 
Low protein 
360+/-99.9 
13.4+/-8.1 
 
<0.001 
0.166 
Kenny et 
al, 2009, 
USA, 1y 
Parallel 112(6)g/d 
Placebo 
Soy protein 
(I) vs. Mixed 
control 
protein 
(Casein, 
Women 
over 60 
years 
old 
(mean=
71y) 
 
Change in 
FNBMD 
Change in 
LSBMD 
 
 
24 
 
 
24 
 
Mean(SEM) 
0.001+/-0.005 
 
 
0.001+/-0.008 
 
 
22 
 
 
22 
 
Mean(SEM) 
-0.003(0.005) 
 
 
0.010+/-0.007 
 
 
0.317 
 
 
0.181 
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Whey and 
Egg) (p). 
No 
isoflavones 
in these two 
study arms 
BAP 
 
NTX 
 
24 
 
24 
 
 
18.8+/-1.07 
 
30.2+/-2.74 
22 
 
22 
25.2+/-2.03 
 
35.0+/-3.21 
0.050 
 
0.50 
Kerstsetter 
et al, 2015, 
USA, 
18mo 
Parallel No 
information 
in g 
45g Whey 
protein (I) or 
isocaloric 
maltodextrin 
(p) 
Men 
over 70 
y and 
women 
over 60 
years, 
n=121 
 
LSBMD 
TotalHipBMD 
FNBMD 
 
LSBMD 
P1NP nmol/L 
CTX ng/L 
OC nmol/L 
 
 
 
106 
106 
106 
 
106 
61 
61 
61 
Mean(SEM) 
1.05(1.10+/-0.01) 
1.06(0.88+/-0.01) 
1.06(0.80+/-0.01) 
 
45(99.3+/-4.29) 
1.32+/-0.06 
480+/-30 
1.12+/-0.05 
 
102 
102 
102 
 
102 
60 
60 
60 
  
Mean(SEM) 
1.02(1.11+/-
0.02) 
1.02(0.89+/-
0.01) 
1.02(0.82+/-
0.01) 
 
44(106+/-4.07) 
1.35+/-0.07 
440+/-30 
1.18+/-0.06 
 
- 
- 
- 
 
- 
0.395 
0.041 
0.775 
 
Kerstetter 
et al, 1999, 
USA, 4d 
 
Cross-over (17-18% of 
total energy)  
High 
(2.1g/kg/d)vs 
low 
(0.7g/kg/d) 
protein 
16 Pre 
F, 20-
40g 
 
OC 
BAP 
NTX 
 
- 
- 
- 
Mean+/-SEM 
5.7+/-0.8 
57.2+/-7.8 
48.2+/-7.2se 
 
- 
- 
- 
Mean+/-SEM 
7.6+/-1.4 
69.4+/-8.8 
32.7+/-5.3 
 
 
Ns 
Ns 
<0.05 
Khalil et 
al, 2002, 
US, 3mo 
 
Parallel No 
information 
in paper 
Soy vs Milk 
protein (40g) 
64 M, 
59.2+/-
17.6y 
BAP 
DPYD 
24 
24 
 
- 
- 
22 
22 
 
- 
- 
Ns 
ns 
Jenkins et 
al, 2003, 
USA, 2mo 
Crossover 
Cross-over 63(15) g/d  Vegetable  
diet (27% 
protein) vs 
Control  
diet(16% 
protein) 
20 
Middle 
aged 
M/F 
NTX 
BAP 
20 
20 
584+/-340 
20+/-4.5 
20 
20 
461+/-259 
19+/4.5 
- 
- 
 
Lampl et 
al. 1978, 
New 
Guinea, 8 
mo 
Parallel 69(17) g/d  Normal diet 
(11g/d)(p) 
vs. normal 
diet plus 
20g/d milk 
protein 
7-13 
year old 
children 
with 
low 
Periosteal 
breadth (mm) 
Endosteal 
breadth (mm) 
Compact bone 
breadth (mm) 
26 
 
26 
 
26 
5.9+/-0.1 
 
2.8+/-0.1 
 
3.1+/-0.1 
30 
 
30 
 
30 
5.7+/-0.1 
 
2.8+/-0.1 
 
2.8+/-0.1 
 
<0.05 
 
ns 
 
ns 
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supplement(I
) 
protein 
intakes 
Mean+/-SEM 
Martin-
Bautista, 
2011, 
Spain 4 mo 
Parallel 1.1 kg/d Collagen 
(without 
calcium) 
group vs. 
Placebo 
38  
BAP 
OC 
TRAP 
CTX 
 
20 
20 
20 
20 
GP 2 
2.35+/-42.6 
-4.0+/-8.1 
-1.2+/-4.0 
0.03+/-0.44 
 
18 
18 
18 
18 
GP 1 
-28.6+/-29.9 
-2.1+/-14.3 
1.6+/-4.2 
0.07+/-0.43 
 
 
NS 
NS 
NS 
<0.05 
Roughead 
et al, 2003, 
USA, 8wk 
 
Cross-over No 
information 
in g 
High meat 
(20% of 
energy) 
versus low 
meat(12% of 
energy) diet 
15 POM 
F 
 
HPO 
OC 
NTX 
BAP 
 
15 
15 
15 
15 
High 
71.5 
4.01 
3.79 
18.1 
 
15 
15 
15 
15 
Low 
64.5 
3.94 
3.83 
18.3 
 
0.001 
Ns 
Ns 
Ns 
Schurch et 
al, 1998 
Switzerlan
d, 6mo 
Parallel (18% of total 
energy) 
Total protein 
(20g/d)  vs 
placebo 
82 
Elderly 
M/F 
80.7y+/-
7.4 
%change 
DPYD 
FSBMD 
LSBMD 
OC 
PFBMD 
PYD 
TrochBMD 
TBBMD 
 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
 
-9.2 
-1.61 
-3.05 
7.9 
-2.95 
6.6 
-3.02 
-3.77 
 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
 
1.4 
-1.23 
-6.11 
6.9 
-3.37 
17 
-3.65 
-3.1 
 
 
>0.2 
>0.2 
>0.2 
>0.2 
>0.2 
>0.2 
>0.2 
>0.2 
 
Shapses et 
al, 1995, 
USA, 5d 
Cross-over Mean +/-SD  LPHC(0.44g/
Kg/D 
protein, p) 
vs. HPHC 
(2.71g/kg/d, 
I) 
Calcium in 
both 
groups=1600
mg/d 
21-42 
year old 
males 
and 
females 
HPO (mol/mol) 15 0.011+/-0.008 13 0.010 +/-0.007 - 
Spence et 
al, 2005, 
USA, 28d 
per phase 
Cross-over Soy group- 
62.5 (13.7) 
g/d 
Soy protein 
isolate 
without 
isoflavones 
(I) vs. 
N=15 
POM F 
BAP ng/mL 
OC  ng/mL 
NTX  
nmolBCE/mmol
Cr 
15 
15 
15 
 
 
14.8+/-4.5 
10.2+/-3.9 
48.0+/-22.6 
15 
15 
15 
 
 
14.3+/-4.0 
8.1+/-3.8 
55.6+/-29.0 
<0.05 
<0.05 
ns 
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casein-whey 
protein (p) 
 
Tkatch et 
al, 1992, 
Switzerlan
d, 38days 
Parallel Mixed 
control 
group- 
57.0(21.9) 
20.4g/d 
Protein in 
nutritional 
supplement  
vs. the same 
nutritional 
supplement 
without 
protein 
62 M/F 
elderly, 
mean 
age 82y 
Change: 
FNBMD 
FSBMD 
LSBMD 
OC 
 
25 
24 
25 
24 
 
0.569+/-0.105 
0.24+/-0.049 
0.88+/-0.18 
6.94+/-2.45 
 
 
 
23 
22 
23 
18 
 
0.579+/-0.12 
1.257+/-0.3 
0.81+/-0.17 
4.96+/-2.93 
 
 
 
 
<0.05 
Toba et al 
2001, 
Japan, 16d 
Parallel 1.0g/Kg/d  MBP 
(30mg/d) vs 
inactive 
placebo 
30 M, 
36.2y+/-
8.5 
NTX 
OC 
30 
30 
 
26.8+/-9.6 
5.4+/-1.8 
30 
30 
31.5+/-10.2 
3.7+/-1.8 
<0.001 
<0.001 
Uenishi et 
al, 2007, 
Japan, 6mo 
Parallel Mean 
(SEM): 
40mg/d 
MBP vs 
inactive 
placebo 
35 Pre F LSBMD 
%change in 
LSBMD 
17 
17 
1.16+/-0.14 
 +1.75% 
18 
18 
1.13+/-0.16 
+0.13% 
- 
0.042 
Vupadhya
hula et al, 
2009, USA 
Parallel 72.9(1.8) 
Maltodextrin 
Group 
25g soy 
protein (no 
isoflavones), 
25g milk 
(casein, 
whey) 
protein 
203 
POM F 
Mean 
(SE) age 
64  
0.6)y 
 
SpineBMD 
FNBMD 
TrochBMD 
TotalFemoralB
MD 
TBBMD 
 
%change from 
baseline: 
NTX:Cr 
 
48 
48 
48 
48 
48 
 
 
 
22 
 
 
 
Mean+/-SE 
1.068+/- 0.02 
0.845+/-0.01 
0.741+/-0.01 
0.892+/-0.02 
1.078+/-0.01 
 
 
 
2.27+/-2.1 
 
 
 
52 
52 
52 
52 
52 
 
 
 
30 
Mean+/-SE 
1.082+/-0.02 
0.869+/-0.01 
0.747+/-0.01 
0.897+/-0.01 
1.094+/-0.01 
 
 
 
-1.86+/-2.3 
 
- 
- 
- 
- 
- 
 
 
 
- 
Yamamura 
et al, 2002, 
Japan 
 
Parallel 73.9(1.9) 
Whey Group 
MBP(40mg)  
vs inactive 
placebo 
33 Pre F RBMD 17 -Missing data 16 -Missing data - 
Zhu et al, 
2011, 
AUS, 2y 
Parallel No 
information 
in paper 
High protein 
drink (I) vs. 
219  70-
80 year 
 
Total Hip 
vBMD 
 
 
67 
Mean(SEM) 
 
-3.63+/-1.10 
 
 
66 
Mean(SEM) 
 
-3.82+/-1.43 
- 
- 
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low protein 
drink (p) 
old 
women 
FN vBMD 
 
Baseline FN 
aBMD 
2 yr FN aBMD 
67 
 
91 
 
91 
 
-2.39+/-1.25 
 
0.70+/-0.010 
 
0.69+/-0.010 
66 
 
88 
 
88 
-0.24+/-1.19 
 
0.71+/-0.012 
 
0.70+/-0.012 
 
 
0.35 
 
0.33 
Zou et al 
2009, 
China, 8 
mo 
Parallel 11g/d Milk with 
40mg MBP 
(I) vs. Milk 
without MBP 
(p) 
57 
women, 
20 years 
old 
TBBMD 
LSBMD 
DistalRadius/Ul
na BMD 
29 
29 
29 
 
0.946+/-0.064 
1.041+/-0.118 
0.351+/-0.041 
28 
28 
28 
0.913+/-0.053 
0.995+/-0.068 
0.341+/-0.036 
- 
- 
- 
 
aBMD, areal Bone Mineral Density; BAP, Bone Specific Alkaline Phosphatase; BCE, Bovine Collagen Equivalents; BMD, Bone Mineral Density; Cr, Creatinine; CTX, C-
terminal telopeptide of collagen; DPYD, Deoxypyridinoline; FNBMD, Femoral Neck Bone Mineral Density; FSBMD, Femoral Shaft Bone Mineral Density; GP, Group; 
HCHP, High Calcium High Protein; HCLP, High Calcium Low Protein; HPO, Hydroxyproline; IntertrochBMD, Intertrochanter Bone Mineral Density; LCHP, Low Calcium 
High Protein; LCLP, Low Calcium Low Protein; LSBMC, Lumbar Spine Bone Mineral Content; LSBMD, Lumbar Spine Bone Mineral Density; NTX, N-terminal 
telopeptide of collagen; OC, Osteocalcin; P1NP, Procollagen type 1 N-terminal propeptide; PERI, Perimenopausal; PFBMD, Proximal Femur Bone Mineral Density; POM, 
Postmenopausal; PRE, Premenopausal; RBMD, Radial Bone Mineral Density; TBBMD, Total Body Bone Mineral Density; TRAP, Tartrate Resistant Alkaline Phosphatase; 
TrochBMD, Trochanter Bone Mineral Density; vBMD, volumetric Bone Mineral Density 
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Figure S1 Femoral Neck Bone Mineral Density- correlation coefficients for association with dietary protein intake*=multivariate 
adjusted data 
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Figure S2 Lumbar Spine Bone Mineral Density- correlation coefficients with dietary protein intake *=multivariate adjusted data 
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Figure S3  Total Protein intake and Hazard Ratio for Fracture (cohort studies) Lowest 
intake category=reference (OR=1) 
 
 
Figure S4 Protein intake and Odds Ratio of Fracture (case control studies) Lowest 
intake category=reference (OR=1) 
 
 
Figure S5 Effects of Total Protein intake on areal Lumbar Spine Bone Mineral Density 
in randomized controlled trials 
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Figure S6: Effects of Total Protein intake on areal Femoral Neck Bone Mineral Density 
in randomized controlled trials 
 
 
 
Figure S7: Milk Basic Protein supplementation: Effects on Lumbar Spine Bone Mineral 
Density 
82 
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